rfhg_51574.1

Basic information about the TSS

---

TSS ID: rfhg_51574.1 Species: human Chr: chr3		Start: 150408654 End: 150408668 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3500298,EH38E2248000)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000361875.7:-319 AB014569:-319 GeneID: 9819 HGNC/MGI_ID: HGNC:29095 UniProt_ID: O75157 Nearer transcript ids and distances: BC044643:333 NM_001303264.2:-356 NM_014779.4:-356 NR_130136.2:-356 AK297383:-361 LF206128:-398 MA441705:-398 view more...

Gene_name: TSC22 domain family member 2 Gene_symbol: TSC22D2 Gene_synonyms: KIAA0669 TILZ4a TILZ4b TILZ4c Gene_source: HGNC:29095

TATA-Box annotation

---

Distance to TSS:	363
Nearest PromoterID:	NM_014779
Entrez ID:	9819
Nearest Unigene:	Hs.722470
Nearest Refseq:	NM_014779
Nearest Ensembl:	ENSG00000196428
Gene Name:	TSC22 domain family member 2
Gene Alias:	TILZ4a|TILZ4b|TILZ4c
Gene Type:	protein-coding
CpG%:	0.071429
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TSC22D2 p2@TSC22D2 p3@TSC22D2 p4@TSC22D2 p5@TSC22D2 p6@TSC22D2 p7@TSC22D2 p9@TSC22D2
Sample		p1@TSC22D2	p2@TSC22D2	p3@TSC22D2	p4@TSC22D2	p5@TSC22D2	p6@TSC22D2	p7@TSC22D2	p9@TSC22D2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	19.87	3.31	5.65	5.45	1.56	3.90	1.36	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.28	2.63	3.03	6.07	1.01	4.45	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.99	1.93	3.09	4.63	2.31	5.79	0.58	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	19.96	1.25	3.53	3.74	0.62	8.73	0.62	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.27	1.35	2.02	3.60	1.57	10.12	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.29	1.74	3.68	3.49	2.33	6.59	0.97	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.13	2.18	2.83	4.58	1.31	1.53	0.44	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	17.68	1.45	2.18	5.33	1.94	2.18	0.97	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.10	1.28	2.99	3.63	1.92	1.50	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	33.04	1.74	4.64	4.06	1.16	2.32	2.90	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.13	1.62	4.85	7.68	2.02	1.62	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	32.93	3.25	2.44	7.32	2.03	6.10	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.35	8.54	3.06	2.26	1.45	0.81	1.13	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.62	5.56	2.26	2.41	1.20	0.90	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.12	6.37	2.85	2.20	2.20	0.44	1.32	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.55	5.78	2.01	1.76	0.75	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.48	5.02	1.31	0.44	1.09	0.44	0.66	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.55	4.64	1.69	2.95	2.53	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	6.93	0.53	3.73	1.60	0.53	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.84	7.22	2.71	2.71	2.26	1.50	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.03	9.49	2.14	3.34	2.54	1.47	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.05	10.18	2.24	2.93	1.73	0.86	1.38	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.82	5.43	1.81	1.81	2.33	1.03	1.29	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	6.31	1.70	2.18	2.91	1.70	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.45	6.45	2.84	2.58	1.81	1.03	0.77	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	5.06	0.95	2.53	1.27	0.32	1.27	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.89	7.14	2.20	1.65	4.95	2.75	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.44	6.13	3.30	3.77	1.65	0.94	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.63	3.39	2.58	3.07	1.13	1.13	0.48	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.04	5.43	2.35	1.63	1.81	0.72	2.90	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	2.30	1.88	1.05	0.63	0.63	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.33	2.54	1.76	1.37	0.59	1.37	1.37	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	4.22	1.90	1.69	1.06	1.06	0.84	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	4.78	2.47	1.65	1.65	0.49	0.33	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.04	3.18	1.87	1.87	0.93	1.12	0.56	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.43	4.60	1.92	1.34	1.15	1.15	1.34	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.61	4.09	2.45	0.61	0.82	0.61	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.25	3.63	1.01	1.21	1.01	1.01	0.60	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.10	3.24	2.16	1.35	0.81	1.62	1.35	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.36	0.96	1.92	1.92	1.68	0.48	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	3.76	2.12	0.71	2.59	0.24	0.71	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.12	2.49	1.46	1.17	0.59	0.15	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.48	3.16	1.05	1.69	0.21	1.05	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.34	2.10	1.22	0.87	0.35	0.35	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.44	1.20	0.80	1.20	0.80	0.40	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.51	1.63	2.09	1.40	0.93	0.70	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.60	1.92	1.44	2.88	0.72	0.72	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.36	1.79	1.49	2.38	1.19	1.19	0.30	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.86	2.87	2.39	1.91	0.96	0.48	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.69	1.62	3.03	1.42	1.62	0.61	0.40	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.76	3.69	1.84	2.05	1.02	0.00	1.02	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.67	2.67	1.56	2.00	1.11	0.89	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.87	1.77	0.71	1.42	1.06	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	1.33	1.33	2.65	0.33	0.66	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.00	1.68	3.36	0.84	0.00	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	4.13	2.76	2.76	0.92	0.46	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.02	0.65	1.62	3.57	0.97	0.65	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.53	0.64	0.96	2.25	0.64	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	1.89	2.51	2.20	1.26	0.00	0.31	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	2.82	1.41	0.71	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	1.12	0.56	2.80	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	3.18	0.80	3.98	0.80	0.00	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.47	2.04	2.04	2.38	0.68	0.34	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.40	1.62	1.30	2.27	1.62	0.32	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	0.35	1.77	3.55	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.90	2.93	1.95	2.44	1.46	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	7.93	0.50	3.47	2.98	0.99	0.99	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	2.35	2.35	1.41	0.94	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.96	4.64	2.65	1.66	1.66	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.88	2.78	1.55	1.86	0.31	0.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.78	1.22	0.61	1.22	1.83	0.00	0.92	0.31
Adipocyte - breast, donor1	11376-118A8	5.54	2.69	2.38	2.22	1.27	0.63	0.48	0.48
Adipocyte - breast, donor2	11327-117E4	6.74	4.81	2.57	1.28	1.28	0.16	2.09	0.48
Adipocyte - omental, donor1	11473-119C6	6.11	2.67	2.42	2.29	2.04	0.51	0.51	0.76
Adipocyte - omental, donor2	11474-119C7	4.48	0.75	2.99	0.75	0.00	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	3.68	3.01	2.01	1.67	0.00	0.33	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	4.47	1.91	1.28	1.28	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1.35	1.81	1.81	0.45	0.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	2.43	1.22	1.22	0.52	0.35	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	15.45	5.08	4.50	4.11	2.93	2.93	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	3.35	2.32	2.57	1.80	1.29	0.51	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	4.18	5.30	2.79	1.67	2.23	0.56	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	5.88	5.29	4.70	1.18	4.11	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	6.60	3.54	4.26	1.53	1.61	0.64	0.16	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	6.78	8.71	5.16	0.65	1.61	0.65	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	5.33	2.13	1.07	3.20	3.20	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.35	6.68	4.45	1.67	0.00	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	3.74	2.91	1.25	0.83	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	4.77	3.01	3.27	1.76	1.26	0.25	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	3.60	2.95	0.65	1.64	0.65	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	2.13	3.04	1.83	0.30	1.52	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	10.17	14.81	2.65	1.77	3.09	3.09	3.98	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	13.98	8.61	1.79	2.51	2.15	3.23	1.79	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	4.79	0.00	0.00	1.20	0.00	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.89	6.66	1.62	1.44	1.80	0.72	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	5.02	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.07	10.48	2.05	0.62	2.88	0.82	2.05	0.41
Anulus Pulposus Cell, donor1	11248-116E6	1.60	1.83	0.57	1.72	0.46	0.23	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	2.94	3.18	2.20	2.45	0.73	0.24	0.24	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.59	4.49	3.59	0.90	0.00	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	2.17	2.17	0.43	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	0.90	2.99	1.49	0.90	0.60	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1.26	3.79	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	0.66	1.98	0.66	0.66	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	2.27	1.62	0.97	0.65	0.32	0.65	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	3.88	1.94	1.46	1.46	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.38	0.59	1.19	0.59	0.59	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1.51	2.64	2.26	0.00	0.75	0.00	1.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	0.73	2.18	0.00	0.00	1.45	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	0.00	0.00	0.00	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	3.79	2.64	1.81	0.82	0.82	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	4.09	1.36	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	2.87	1.21	0.60	0.75	0.60	0.45	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	1.07	2.68	2.14	0.54	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	2.83	2.08	1.89	0.76	0.38	0.57	0.94	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.81	1.60	0.80	2.14	0.53	0.27	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	0.98	1.95	0.98	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	2.49	1.66	1.16	1.00	0.83	0.33	1.16	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1.20	0.00	1.20	2.40	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	7.08	3.54	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	0.69	2.23	0.51	1.03	0.51	0.69	0.51	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	0.97	1.46	0.49	0.97	0.49	0.00	1.46	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.17	3.04	1.14	0.76	0.00	0.38	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	2.42	2.42	0.00	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1.71	1.14	1.14	0.00	0.57	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.49	1.28	0.64	0.86	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	2.58	1.55	1.29	1.03	1.55	0.26	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2.82	1.88	0.00	2.35	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	2.57	2.25	0.96	1.61	0.64	0.00	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	0.00	0.00	0.00	2.85	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	0.00	1.75	2.34	0.00	0.00	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1.81	2.41	2.11	0.90	0.60	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	3.56	0.00	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	2.54	3.05	1.02	1.02	1.02	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	2.80	2.04	0.76	1.27	0.76	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	2.54	2.54	0.64	0.00	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	2.59	4.75	1.73	1.29	0.86	0.43	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	2.96	1.91	1.06	1.27	0.21	0.42	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1.74	1.16	0.58	0.29	0.58	0.29	0.58	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1.89	2.83	0.94	0.00	0.00	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.05	2.20	0.68	1.19	0.51	0.34	0.51	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	2.32	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	0.00	0.00	2.11	2.11	0.00	4.23	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1.50	0.86	0.86	0.21	0.64	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2.41	2.41	1.80	0.60	0.60	0.60	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	0.73	0.73	0.00	0.73	0.00	0.73	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	2.76	0.00	0.23	1.84	0.23	0.00	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1.02	1.02	0.76	0.00	0.51	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1.86	1.86	1.65	1.45	0.21	0.00	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	0.61	2.14	0.92	0.92	0.61	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1.43	0.48	0.48	1.91	0.00	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.44	0.67	0.89	0.67	0.67	0.22	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	0.00	0.00	1.53	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.88	1.66	3.32	0.00	1.11	0.00	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	1.85	3.97	1.06	1.32	0.53	0.26	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	2.54	1.09	0.73	0.00	0.00	0.00	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	16.09	20.88	5.16	3.07	3.56	5.28	0.98	1.84
Astrocyte - cerebellum, donor2	11580-120F5	13.52	20.54	2.40	2.57	3.77	2.40	2.05	1.20
Astrocyte - cerebellum, donor3	11661-122F5	13.63	13.63	3.99	1.68	3.36	3.78	2.73	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	19.87	18.13	4.53	3.49	3.49	2.79	2.44	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	22.81	20.06	5.18	4.21	4.21	3.24	1.13	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	19.54	11.63	5.07	2.68	2.68	1.04	0.60	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.90	1.95	4.93	6.19	1.72	0.80	0.46	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	10.27	1.25	4.64	4.26	1.88	0.50	0.38	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.13	0.57	3.98	5.58	1.25	0.46	0.57	0.80
Basophils, donor1	12241-129G9	22.23	5.49	17.52	6.02	4.71	1.05	9.15	4.45
Basophils, donor2	12242-129H1	19.12	4.33	21.29	7.58	5.05	1.44	16.24	5.41
Basophils, donor3	12243-129H2	30.72	7.50	13.08	6.61	5.00	3.82	16.46	4.70
Bronchial Epithelial Cell, donor1	11511-119G8	3.23	3.88	1.29	1.08	1.08	0.22	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	1.83	2.29	0.46	1.37	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	3.77	0.63	1.26	0.63	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	5.82	3.95	1.04	2.08	0.62	0.42	0.42	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	6.45	2.53	1.38	0.92	1.15	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	3.24	1.26	0.18	0.90	1.26	0.00	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.64	0.10	2.06	2.89	0.82	0.62	2.58	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	6.75	0.47	3.26	2.79	4.43	0.23	1.86	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.87	0.96	5.12	7.35	2.88	2.88	1.28	3.84
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	20.68	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	49.03	22.54	18.03	5.64	10.71	11.27	29.87	3.94
CD14+ Monocytes, donor2	11305-117B9	64.96	17.82	21.72	12.99	9.09	10.76	36.93	8.35
CD14+ Monocytes, donor3	11381-118B4	54.23	18.00	18.66	8.12	7.68	8.56	24.15	7.24
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.38	0.57	3.40	3.96	0.00	0.28	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	5.31	1.14	5.31	1.90	1.52	0.38	0.38	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.92	1.64	6.90	3.29	1.31	0.99	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	22.26	4.48	5.93	5.20	1.59	3.32	4.19	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	22.63	7.54	4.83	3.92	2.72	3.32	4.22	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	25.11	5.92	8.05	7.11	2.61	7.58	4.97	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	40.01	5.52	6.36	3.52	2.68	9.54	3.18	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	47.47	9.94	5.52	3.59	5.24	9.66	5.80	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.00	16.36	9.17	5.45	5.45	26.28	5.95	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	39.75	5.09	5.48	3.92	1.37	9.40	3.52	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	37.75	6.23	8.01	4.81	2.31	14.42	4.27	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	43.96	10.23	11.10	4.57	3.05	13.49	5.88	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	46.36	11.00	5.15	4.92	2.81	23.41	7.73	2.34
CD14+ monocytes - treated with Candida, donor2	11878-125C6	83.43	19.54	10.56	8.45	7.92	32.74	10.56	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	90.97	32.17	8.87	4.44	6.66	67.67	8.87	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	30.94	5.35	6.69	3.27	2.38	5.35	5.21	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	31.53	8.78	5.39	5.39	2.99	4.99	4.99	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	29.98	10.41	8.33	2.29	2.91	9.16	5.20	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	73.21	8.69	10.30	5.26	2.75	34.78	8.01	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	57.23	13.35	12.89	6.56	4.52	23.75	5.43	2.71
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	82.49	13.97	16.15	2.18	6.55	54.56	13.97	4.36
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.33	2.96	6.99	3.23	1.61	1.61	1.61	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.01	5.06	8.20	4.88	2.97	5.23	4.01	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.45	5.47	9.68	5.89	2.95	10.52	5.05	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	42.99	7.16	7.16	2.76	3.12	6.98	4.04	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	46.50	9.51	8.81	5.64	3.52	7.40	4.58	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	63.62	18.87	13.16	5.70	5.70	18.43	7.46	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.63	4.53	3.84	3.84	1.92	13.08	2.96	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	44.60	6.32	7.81	2.97	1.86	16.35	6.32	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	61.22	12.29	10.13	4.74	3.23	25.87	7.98	3.02
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.16	3.69	6.14	1.64	4.09	6.14	5.73	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	39.87	10.43	10.43	4.17	2.32	10.66	3.48	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	47.79	11.37	12.76	3.71	4.18	10.90	4.64	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	8.28	4.58	5.45	3.27	4.58	0.65	5.67	2.62
CD14+CD16+ Monocytes, donor2	11801-124D1	9.24	5.54	7.39	4.16	3.70	1.62	7.85	2.31
CD14+CD16+ Monocytes, donor3	11912-125G4	6.72	3.47	6.07	3.03	3.90	0.65	5.42	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	17.29	6.85	8.88	8.41	7.16	0.93	6.54	3.27
CD14+CD16- Monocytes, donor2	11799-124C8	14.67	5.76	7.86	5.76	5.59	1.40	8.91	2.27
CD14+CD16- Monocytes, donor3	11910-125G2	14.94	8.92	8.47	6.91	7.80	0.45	8.47	1.78
CD14-CD16+ Monocytes, donor1	11790-124B8	11.74	3.32	6.89	4.08	3.83	1.02	7.40	2.55
CD14-CD16+ Monocytes, donor2	11800-124C9	10.10	7.03	6.15	7.25	4.39	1.54	10.10	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	8.00	5.47	7.58	3.16	3.16	0.84	6.74	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	0.00	6.10	10.16	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	0.00	6.10	6.78	6.10	1.36	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	0.00	1.04	8.28	5.18	1.04	1.04	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	14.93	1.60	10.13	6.93	4.80	0.53	0.00	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	10.72	0.54	7.50	12.33	4.29	0.00	1.61	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	8.42	0.00	4.21	6.32	4.21	0.00	0.70	3.51
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	0.00	4.71	3.14	3.14	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	0.00	3.95	10.55	5.27	0.00	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	27.12	1.64	24.66	17.26	3.29	1.64	17.26	9.04
CD19+ B Cells, donor2	11624-122B4	27.57	2.18	29.02	21.76	4.35	2.90	13.78	14.51
CD19+ B Cells, donor3	11705-123B4	19.18	2.02	28.27	17.16	6.06	4.54	14.64	11.61
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	29.09	3.64	8.89	7.27	3.64	0.81	1.62	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.17	1.20	6.39	4.79	3.60	0.80	1.20	3.20
CD34+ Progenitors, donor1	11545-120B6	32.13	5.02	19.08	5.02	5.02	6.02	16.06	11.04
CD34+ Progenitors, donor2	11625-122B5	29.21	8.99	32.02	12.92	2.81	2.25	8.99	12.36
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	3.38	0.38	2.25	4.51	1.13	1.88	0.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	3.61	0.00	2.48	3.38	1.58	0.23	1.58	1.13
CD4+ T Cells, donor1	11225-116C1	28.56	0.00	29.99	11.07	1.79	2.50	10.35	11.78
CD4+ T Cells, donor2	11306-117C1	27.56	1.22	26.94	18.98	4.90	3.06	14.70	17.15
CD4+ T Cells, donor3	11382-118B5	29.58	1.22	20.43	15.55	1.83	2.74	23.48	8.84
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.06	0.26	5.36	5.87	3.57	0.00	0.51	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2.92	0.22	6.06	4.04	6.51	0.22	1.12	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.62	0.57	8.91	4.31	5.75	0.29	1.44	2.30
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.22	0.00	12.33	9.01	2.37	0.47	1.90	4.27
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.13	0.00	9.13	6.32	4.21	0.70	1.40	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	0.00	13.18	9.89	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1.59	0.29	4.19	3.18	2.17	0.72	0.87	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	2.71	0.00	3.22	2.20	3.22	0.17	0.34	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1.77	0.00	4.03	1.61	3.06	0.00	0.16	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	5.83	0.45	6.72	5.38	1.79	0.00	3.59	5.38
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5.59	0.00	6.64	6.99	1.75	0.00	2.45	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.04	0.44	5.72	6.60	2.20	1.32	1.76	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.11	0.00	6.75	7.17	2.53	0.00	0.00	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	4.99	0.21	3.95	3.74	2.91	0.00	0.21	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.34	0.33	5.01	1.67	2.34	0.67	1.67	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.58	0.00	14.41	13.87	2.72	1.09	2.99	3.81
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	13.40	0.00	13.93	11.79	2.14	1.07	3.75	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	10.76	0.00	10.76	12.55	3.59	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.08	0.93	4.82	5.19	5.01	0.74	0.19	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.33	0.22	6.93	3.47	2.17	0.43	0.87	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	4.41	0.00	4.83	6.30	1.89	0.21	1.26	2.31
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	4.55	0.00	20.22	6.57	1.52	0.00	5.56	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.93	0.43	10.83	7.80	2.17	0.43	5.63	5.20
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.90	0.00	10.02	5.23	1.74	0.44	3.49	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10.39	0.49	8.91	6.93	6.93	0.00	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	5.54	0.00	7.39	4.62	3.69	0.00	0.00	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	0.00	8.37	1.40	5.58	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	7.48	0.55	8.31	13.02	2.77	1.11	1.38	4.98
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	5.89	0.49	9.82	8.34	4.91	0.49	0.00	4.42
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	7.70	1.54	6.16	4.62	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	4.66	0.36	11.46	9.67	3.58	0.00	0.36	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	1.38	9.69	13.85	2.77	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	16.37	1.31	37.98	11.46	6.88	3.27	24.23	16.70
CD8+ T Cells, donor2	11307-117C2	33.04	1.50	37.92	16.89	4.88	2.63	30.03	17.27
CD8+ T Cells, donor3	11383-118B6	28.03	0.50	36.86	11.61	3.53	1.77	16.16	11.36
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.38	0.46	2.29	2.98	0.00	1.15	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.12	0.48	1.92	1.92	0.48	0.00	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.74	0.27	0.82	2.46	0.55	0.00	0.55	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.80	0.30	0.60	5.10	0.60	0.30	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.80	0.48	1.68	1.92	0.72	0.48	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.27	0.68	2.05	1.59	0.23	1.36	0.23	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.39	0.22	1.96	2.82	0.22	0.22	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1.32	0.26	2.37	3.42	0.26	0.53	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.11	0.70	0.94	3.52	0.94	0.47	0.00	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1.81	0.91	2.72	2.42	0.00	0.91	0.00	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.61	0.58	1.45	3.20	0.58	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1.87	0.53	1.87	3.46	0.27	0.27	0.00	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.82	8.32	5.69	2.19	3.50	19.70	10.51	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.58	12.30	5.01	4.55	1.37	25.05	11.39	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	5.97	7.46	2.24	3.73	25.36	5.97	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.24	0.72	0.36	1.80	0.36	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.74	0.58	2.30	1.15	0.58	0.29	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.65	0.24	2.83	3.30	0.24	0.47	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.22	0.63	2.54	2.85	0.95	0.63	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.77	0.62	1.85	1.85	0.31	0.31	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.24	0.64	1.92	4.81	0.64	0.32	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.82	0.38	2.29	3.44	0.38	1.15	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	0.79	2.76	3.15	0.79	0.79	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	0.00	4.54	0.76	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	40.15	16.86	12.04	8.03	4.01	26.50	8.03	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.08	13.99	10.49	9.79	2.80	23.78	7.69	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	35.06	9.02	12.02	6.01	4.01	24.04	6.01	4.01
Cardiac Myocyte, donor1	11525-119I4	7.31	10.97	0.00	3.66	5.48	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	0.99	0.49	0.99	1.48	0.49	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	3.37	1.05	1.05	0.74	0.21	0.00	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	5.20	1.39	1.39	0.69	0.35	1.04	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	2.13	1.42	0.71	0.00	1.78	1.07	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	4.55	1.48	0.68	0.80	0.91	0.23	0.34	0.00
Chondrocyte - re diff, donor2	11339-117F7	5.37	3.58	3.58	0.00	0.90	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	13.35	3.64	3.24	1.21	3.64	0.81	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	17.56	15.03	4.25	3.67	4.36	2.64	1.72	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	19.45	23.09	6.63	3.42	5.56	2.35	5.99	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	16.55	15.22	3.54	3.98	2.65	2.39	2.21	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.79	4.31	3.39	6.88	4.77	2.84	0.83	0.37
Corneal Epithelial Cells, donor1	11526-119I5	4.61	2.42	0.00	1.32	1.10	0.00	0.44	0.44
Corneal Epithelial Cells, donor2	11606-120I4	4.55	6.83	0.00	1.14	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.58	6.65	0.00	1.79	2.30	0.26	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4.46	2.64	4.95	3.47	1.16	0.66	1.49	1.82
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.73	1.89	2.52	1.89	1.89	0.32	1.58	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	3.45	3.45	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	4.43	0.32	4.21	2.38	1.08	0.65	1.19	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	8.88	1.37	18.11	7.17	1.37	0.00	5.81	9.91
Dendritic Cells - plasmacytoid, donor2	11309-117C4	4.57	0.65	7.83	3.92	0.65	1.31	4.57	5.22
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.87	0.97	11.13	7.26	1.45	0.97	4.36	7.74
Endothelial Cells - Aortic, donor0	11207-116A1	4.67	3.34	3.00	1.33	0.50	0.50	0.83	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	8.21	1.17	0.59	0.00	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.35	3.11	1.98	2.26	1.41	0.57	1.13	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	7.86	2.36	2.75	1.57	0.79	0.79	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	4.07	1.45	0.29	0.87	0.00	0.29	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	6.59	4.00	2.82	2.12	0.47	0.94	0.47	0.71
Endothelial Cells - Artery, donor3	11413-118E9	7.71	3.68	1.40	1.58	1.05	0.88	1.75	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.10	3.32	1.99	1.55	0.00	0.89	1.33	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	5.78	5.17	2.74	1.22	1.52	0.61	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	6.20	4.79	2.26	1.13	1.13	0.28	0.56	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	2.38	1.19	0.59	0.89	0.89	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	4.69	1.04	1.56	0.52	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.40	0.57	0.71	0.57	0.28	0.43	0.28	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	8.40	2.00	2.80	1.20	1.60	0.40	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	1.57	2.10	1.05	0.52	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	8.82	2.61	3.48	2.48	1.62	0.12	0.75	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	4.13	3.48	2.82	2.17	2.39	0.22	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6.35	4.27	2.44	1.22	2.08	0.12	0.37	0.85
Endothelial Cells - Vein, donor1	11267-116G7	9.10	2.28	3.41	3.41	1.14	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	11.18	2.79	3.49	2.79	0.00	0.00	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	7.54	2.36	1.88	1.26	0.47	0.47	0.31	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	155.12	36.31	41.26	4.95	21.45	6.60	66.01	11.55
Eosinophils, donor3	12246-129H5	135.54	64.20	32.10	24.97	7.13	7.13	28.53	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	1.95	3.18	0.98	1.22	0.98	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	2.08	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.98	3.69	2.05	1.23	0.82	0.82	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.86	0.66	0.11	0.22	0.44	0.22	0.11	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.66	1.73	0.54	1.73	1.08	0.54	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	6.67	3.40	2.18	2.79	1.09	0.73	1.09	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.55	6.82	1.50	0.55	3.00	1.91	2.87	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.32	1.90	1.05	1.79	0.42	0.53	0.21	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.80	5.53	3.43	4.48	1.84	2.11	1.32	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	7.31	2.33	1.99	1.66	1.33	0.66	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	5.44	1.81	1.36	0.91	0.91	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.06	3.03	1.52	3.03	0.76	0.00	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	3.94	0.79	1.26	0.63	0.47	0.16	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	7.58	4.55	1.21	0.91	0.61	0.30	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	5.46	2.66	1.90	2.03	1.02	0.38	0.00	0.63
Fibroblast - Cardiac, donor6	11460-119B2	7.12	2.43	1.21	1.36	1.67	0.76	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.03	3.08	2.81	1.61	0.67	0.54	0.27	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	2.16	2.16	2.16	2.16	2.59	0.86	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	1.46	0.00	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.07	9.69	5.30	2.31	3.46	0.23	0.92	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	3.22	2.04	1.70	1.19	1.36	0.17	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	2.11	2.58	1.88	0.70	0.47	0.47	1.41	0.00
Fibroblast - Dermal, donor2	11346-117G5	2.83	4.72	1.42	2.36	0.94	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	2.42	1.69	1.21	0.73	1.21	0.12	0.60	0.48
Fibroblast - Dermal, donor4	11450-119A1	5.43	5.09	2.15	2.71	2.15	0.45	0.00	0.68
Fibroblast - Dermal, donor5	11454-119A5	9.59	9.07	3.84	3.14	3.84	0.35	0.35	1.40
Fibroblast - Dermal, donor6	11458-119A9	10.88	9.91	3.41	3.90	3.25	0.65	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	1.87	4.58	2.08	1.46	1.46	0.21	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	10.22	8.12	2.88	3.14	3.41	0.52	1.57	0.79
Fibroblast - Gingival, donor2	11318-117D4	8.30	7.78	2.64	1.58	4.09	0.13	0.92	0.53
Fibroblast - Gingival, donor3	11394-118C8	5.90	3.29	3.00	0.77	1.45	0.00	0.29	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	7.27	0.00	3.12	1.04	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.81	5.29	2.29	0.70	0.88	1.23	0.53	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.75	21.51	5.61	3.59	6.70	3.74	4.68	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.60	12.85	3.79	1.89	2.70	1.35	1.49	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	39.52	15.17	13.41	7.06	1.41	6.35	2.47	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.51	11.11	6.58	2.05	3.51	1.32	1.32	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	7.64	7.36	2.18	1.36	2.32	1.23	1.36	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.80	16.02	5.05	3.95	2.52	2.41	1.10	1.65
Fibroblast - Gingival, donor9 (control)	11927-125I1	10.57	8.07	3.96	3.08	3.67	1.17	0.73	0.59
Fibroblast - Lung, donor1	11270-116H1	5.44	5.44	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	4.48	2.98	4.48	1.49	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	3.59	1.90	1.90	1.90	0.00	0.21	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	5.00	4.17	2.50	0.00	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	2.80	0.00	4.20	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	2.52	1.96	1.96	0.56	0.00	1.68	0.28
Fibroblast - Mammary, donor1	11540-120B1	4.87	8.93	4.87	1.62	0.81	0.41	0.41	2.03
Fibroblast - Mammary, donor2	11620-122A9	3.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.21	7.56	2.72	2.13	4.27	0.39	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	10.16	8.34	5.01	3.19	4.40	0.61	0.46	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	5.81	9.79	2.75	1.53	3.06	0.92	1.53	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.16	19.84	1.53	1.53	2.29	0.38	0.76	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.07	11.61	2.97	2.97	1.08	0.81	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	7.89	6.03	2.44	1.16	1.62	0.81	0.58	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	3.76	2.54	1.55	0.66	0.44	0.55	0.11	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.67	4.06	3.66	1.02	0.61	0.00	1.02	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.68	4.01	1.34	2.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.56	3.16	0.40	0.40	1.58	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.07	18.85	6.15	6.95	4.96	4.37	4.37	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.53	7.46	2.13	0.71	1.42	0.71	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6.70	8.87	2.56	0.79	1.38	0.59	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.73	22.86	4.81	4.81	5.42	3.91	6.62	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.82	14.90	2.37	2.16	2.37	1.30	1.94	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.40	12.91	5.06	3.29	1.52	2.78	4.30	1.27
Fibroblast - skin normal, donor1	11553-120C5	4.92	9.02	1.31	0.82	1.31	0.82	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	15.44	29.88	6.42	3.81	5.01	3.61	11.03	1.20
Fibroblast - skin normal, donor2	11561-120D4	8.14	13.36	4.32	1.81	2.41	1.61	1.61	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	14.21	27.20	4.23	6.35	3.93	3.63	4.53	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.44	10.69	2.57	0.75	2.32	1.41	1.16	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	4.79	4.10	0.51	1.71	1.71	0.51	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.50	13.79	4.60	3.94	3.94	4.27	4.60	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.42	10.01	2.24	2.56	1.49	1.60	0.96	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	8.77	7.76	1.18	1.01	1.35	1.01	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2.20	4.55	0.63	0.94	0.94	0.16	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	6.97	0.87	0.87	4.36	0.87	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	6.07	5.37	1.21	0.87	1.56	1.73	1.56	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.71	7.29	1.30	2.08	2.34	0.52	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.96	8.94	1.79	0.51	1.02	1.79	1.02	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.83	2.30	3.83	6.12	1.53	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.10	0.64	1.91	5.74	1.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.12	0.86	1.71	6.56	1.14	0.57	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.78	0.55	4.96	16.27	1.93	0.00	0.00	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.00	2.28	3.65	9.82	3.42	1.83	0.23	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	17.63	0.79	2.97	7.73	0.79	0.20	0.99	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	21.68	0.53	7.14	14.80	1.06	0.79	0.26	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.72	3.26	3.91	12.07	1.96	0.33	0.65	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	10.61	0.44	2.65	5.75	0.88	0.00	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	3.39	0.85	1.84	5.51	1.41	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	12.44	3.57	2.09	5.54	3.45	0.49	0.74	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.72	0.00	1.07	1.88	1.88	0.27	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	9.29	1.73	2.23	5.70	1.36	0.50	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7.89	2.77	2.91	5.26	1.38	0.28	0.55	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.90	1.63	1.63	4.27	1.22	0.61	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.15	2.05	2.28	3.19	1.14	0.68	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.85	2.12	3.11	3.11	1.99	0.37	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.15	2.84	2.40	3.06	2.19	0.66	0.00	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	9.16	0.89	2.36	4.43	1.18	0.59	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	8.90	1.43	3.02	3.50	0.48	0.16	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.28	2.68	2.46	2.46	2.01	0.67	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.70	1.01	0.81	3.23	1.21	0.40	0.20	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	6.28	1.70	1.19	4.07	1.02	0.51	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	11.62	2.31	2.84	3.90	1.51	1.06	0.62	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.12	3.64	2.71	5.62	3.64	0.31	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.37	2.56	1.88	5.12	3.42	0.34	0.34	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	7.75	1.22	1.44	4.32	1.11	0.33	0.33	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	8.49	1.58	2.33	3.16	1.08	0.25	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.21	1.43	1.63	2.65	1.02	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.08	2.06	1.24	3.30	1.86	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.11	1.61	1.50	4.61	1.38	0.23	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	9.01	2.50	1.83	3.50	1.00	0.33	1.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	11.46	0.88	1.98	3.31	2.20	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	14.27	2.46	1.35	2.95	1.48	0.37	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.75	1.30	1.62	4.54	1.30	0.81	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.51	1.92	3.21	1.92	1.92	0.32	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	8.62	1.04	0.57	3.60	1.52	0.19	0.38	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.33	1.27	2.06	3.80	1.90	0.16	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.73	0.61	1.22	4.26	1.82	0.30	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	8.05	1.15	1.46	3.24	1.15	0.42	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.68	1.54	1.32	3.07	1.10	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	10.38	1.96	1.40	2.81	1.12	0.56	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	8.80	1.94	1.57	4.07	2.22	0.65	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5.62	1.07	1.60	3.48	0.27	0.27	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.34	1.22	1.22	3.37	1.53	0.15	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.66	0.91	1.04	3.63	0.52	0.26	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	6.78	1.63	1.36	1.90	0.81	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.85	2.21	1.84	1.84	2.58	0.55	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	7.90	3.95	0.66	2.41	1.10	1.10	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	3.97	2.98	4.96	3.97	0.99	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.10	6.20	1.98	1.58	1.71	0.53	1.19	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	6.66	4.44	2.22	2.22	1.01	0.81	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	19.32	6.35	3.05	6.10	4.57	1.02	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.17	0.80	1.79	5.37	1.79	0.00	0.20	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.17	1.23	2.93	6.78	3.08	0.15	0.15	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.50	0.82	3.27	7.77	2.25	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.32	0.31	0.63	5.95	0.31	0.63	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	0.00	0.57	3.96	0.28	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.76	0.46	1.84	7.84	0.92	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	0.00	0.00	7.42	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.12	0.77	1.93	2.71	0.39	0.00	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	3.21	1.60	9.63	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	0.00	1.74	13.91	3.48	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	6.18	0.00	1.95	5.21	0.65	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.06	0.41	3.29	5.77	0.82	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	3.33	6.66	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.07	0.28	1.96	3.36	0.00	1.40	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.17	0.98	1.63	3.60	0.65	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	0.84	2.52	6.71	1.68	0.00	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.45	0.95	2.54	4.77	2.54	0.95	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.85	0.34	4.08	6.11	1.36	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	0.00	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	13.17	1.72	2.86	10.31	1.72	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.22	1.78	1.18	2.37	1.18	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	0.00	5.08	6.78	1.69	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	10.36	2.07	1.66	3.73	1.24	0.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.66	1.38	2.99	5.52	1.61	0.46	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.84	1.15	2.31	5.77	1.54	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.11	1.96	1.96	4.89	1.63	0.98	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.03	0.00	2.68	3.34	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.88	1.93	1.93	5.39	1.16	0.39	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.36	6.50	6.16	5.14	3.08	3.08	1.03	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	2.48	2.48	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	10.38	4.25	3.77	7.55	2.36	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.69	1.21	1.81	4.83	1.81	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.33	2.03	2.54	4.07	2.03	1.02	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.76	0.80	0.00	2.39	1.99	0.40	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.33	0.99	3.45	2.47	1.97	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	11.80	3.54	7.08	10.62	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.00	1.17	1.75	6.42	2.33	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.68	4.83	3.95	7.90	2.63	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	13.56	1.70	3.39	8.48	2.54	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	9.55	2.39	1.19	7.16	1.19	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.68	3.88	1.94	6.31	0.00	0.49	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	2.28	0.00	2.28	2.28	3.42	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	7.90	0.42	1.25	0.83	2.91	2.08	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	14.62	3.37	2.25	1.12	2.25	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.17	4.44	0.95	1.59	0.00	1.27	1.27	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	0.84	2.92	0.00	0.84	0.42	2.09	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	3.60	0.46	0.12	1.16	0.46	0.46	0.12	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.87	0.34	0.17	1.18	1.52	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.10	0.91	0.00	1.82	0.46	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.28	1.53	0.55	1.42	1.31	0.33	0.11	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2.15	2.15	0.43	0.43	1.07	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.44	1.08	0.43	1.29	1.08	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.87	1.62	0.25	0.25	0.87	0.25	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.77	3.09	0.34	0.86	0.34	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1.92	0.96	0.00	0.96	0.32	0.00	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.36	1.12	2.80	1.68	1.12	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	7.36	1.30	4.33	1.30	1.73	0.43	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	2.64	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.64	6.35	3.17	1.41	0.71	1.06	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	5.81	2.18	0.00	1.45	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	2.27	1.05	0.87	1.22	0.70	0.17	0.35	0.35
Hepatocyte, donor1	11523-119I2	7.26	3.63	3.63	2.42	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	6.46	3.23	5.39	1.08	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	9.20	11.66	5.52	1.84	3.07	2.45	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.83	0.65	5.87	9.79	0.00	0.00	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	7.52	2.10	1.75	3.85	2.27	0.00	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	6.72	12.90	1.37	0.96	2.06	1.78	1.65	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	9.55	3.18	6.37	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	9.69	6.92	11.08	1.38	1.38	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	5.01	2.50	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	12.81	0.00	10.25	7.69	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	9.14	4.57	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	9.75	8.12	12.99	1.62	0.00	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	1.67	10.00	3.33	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63	3.63	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	11.91	5.29	6.62	2.65	1.32	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	2.22	3.33	4.43	2.22	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	8.19	1.89	5.67	3.15	0.63	1.89	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	4.64	1.55	6.19	3.09	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.80	7.75	2.58	6.46	1.94	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	8.05	8.05	9.66	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	9.78	4.07	5.70	0.81	0.81	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	6.30	0.84	4.20	3.36	1.68	0.00	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	10.45	8.84	3.21	9.64	4.82	0.80	0.00	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	1.85	2.77	5.54	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.78	2.36	4.25	6.14	1.42	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	3.63	4.53	7.26	0.91	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	9.69	4.30	8.61	2.15	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	7.62	2.54	3.81	1.27	1.27	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	32.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	13.39	7.65	5.74	8.29	1.28	0.64	2.55	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	9.11	3.65	1.82	3.65	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	3.57	7.85	6.43	4.28	0.71	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	16.59	6.64	3.32	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.86	4.32	3.09	6.17	3.40	2.16	0.00	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	10.54	5.27	5.27	1.76	0.00	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	15.72	6.29	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	6.95	6.95	6.26	4.17	2.09	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	8.85	2.21	0.00	2.21	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	9.73	0.00	6.48	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	13.08	7.85	7.85	3.49	0.00	0.87	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	9.00	6.75	9.00	4.50	0.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	3.48	6.97	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	8.53	2.13	6.40	3.20	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	22.17	2.77	5.54	5.54	0.00	2.77	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	14.25	5.70	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	6.44	7.36	7.36	8.28	0.92	0.92	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	15.13	0.00	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	12.42	6.21	0.00	18.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	5.29	4.23	10.57	5.29	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	5.47	5.39	0.73	1.71	1.31	1.06	1.06	0.16
Keratinocyte - epidermal, donor2	11349-117G8	1.17	0.59	0.00	0.00	1.17	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.49	2.84	0.09	1.23	1.14	0.09	0.57	0.09
Keratinocyte - oral, donor1	11251-116E9	7.38	3.63	1.70	1.70	3.52	0.57	0.45	0.45
Keratocytes, donor1	11527-119I6	7.91	9.97	4.81	1.72	1.03	0.34	0.00	0.69
Keratocytes, donor2	11607-120I5	5.86	5.86	1.17	0.00	0.00	3.52	1.17	2.34
Keratocytes, donor3	11688-122I5	5.73	5.53	3.16	2.37	3.75	0.20	0.40	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	4.40	2.20	0.00	6.59	2.20	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	7.55	15.10	1.08	1.08	2.16	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	9.11	4.96	2.08	2.19	1.61	0.35	0.58	0.46
Lens Epithelial Cells, donor3	11690-122I7	6.76	7.77	2.42	2.42	2.83	0.81	1.61	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.62	2.25	1.66	0.95	0.47	0.71	0.47	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.19	1.67	1.12	1.95	0.84	3.35	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4.88	0.79	1.73	1.10	0.63	0.31	0.16	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	0.00	0.54	0.54	0.54	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.67	1.89	0.63	1.26	0.32	3.15	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.02	0.54	0.43	0.54	0.54	0.32	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	1.23	2.46	1.64	1.23	5.75	1.23	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.07	1.52	1.01	1.01	0.76	2.53	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.08	0.99	0.42	0.99	0.99	1.13	0.28	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.52	2.37	1.58	1.58	1.19	3.56	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.69	3.10	2.52	1.94	1.55	8.14	0.78	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.04	0.74	0.56	0.37	0.56	1.11	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	2.09	1.39	0.00	0.70	6.62	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.50	3.34	1.91	2.15	0.48	8.35	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.94	1.51	1.51	0.69	0.14	0.82	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.32	2.46	1.54	1.54	1.23	4.62	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	1.87	0.94	0.62	0.31	5.30	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.76	1.28	1.65	1.46	0.18	0.73	0.73	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	4.94	1.97	0.33	0.99	6.25	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.32	1.76	1.17	2.34	0.88	2.93	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.49	1.74	1.00	0.75	0.50	0.50	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.67	3.39	0.97	0.48	1.45	10.67	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.00	4.58	1.89	1.62	0.81	9.43	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	2.72	0.91	1.06	0.45	0.76	1.36	0.76	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	3.63	1.56	0.52	1.56	4.67	1.04	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.29	3.77	1.88	1.68	1.68	10.68	1.26	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.01	0.60	0.90	0.90	1.20	1.50	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	2.75	1.38	1.38	0.69	2.75	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.35	2.63	1.32	1.13	0.75	5.46	0.94	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.33	0.74	1.06	0.85	0.32	0.95	0.42	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.30	2.42	0.48	0.97	1.45	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.95	1.65	1.32	0.66	0.00	3.64	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.10	0.74	0.62	0.37	0.25	1.24	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.66	0.74	2.22	0.37	1.48	0.00	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	2.96	1.48	1.73	1.73	4.94	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.71	0.27	0.55	0.41	0.41	0.27	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.40	2.25	0.64	2.89	0.32	1.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.91	4.56	2.13	1.22	3.04	4.56	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.74	1.68	0.42	1.68	0.98	1.26	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	2.13	2.13	1.42	0.36	1.07	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	3.39	1.94	0.00	0.48	5.33	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.18	0.78	0.47	0.93	0.47	0.78	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	2.86	2.15	0.36	0.72	1.43	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.19	2.94	2.61	2.29	0.65	4.25	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.88	0.71	0.24	0.47	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	6.06	1.24	1.24	0.87	1.36	0.50	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	2.05	1.02	1.28	0.77	1.02	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.69	0.30	0.00	0.60	0.60	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	9.06	4.53	6.80	4.53	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	10.74	3.07	4.60	3.07	5.37	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	11.13	0.74	2.97	2.23	7.42	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.62	15.66	1.27	5.50	5.08	5.50	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	15.47	11.25	0.70	3.52	1.41	4.92	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	2.80	0.93	4.67	4.67	6.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	10.82	1.55	4.12	4.12	5.67	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	4.76	1.19	7.14	7.14	3.57	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.46	14.70	1.13	4.52	8.14	5.43	1.58	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	20.65	10.18	2.04	4.07	4.07	6.98	2.33	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	18.91	14.41	1.80	3.15	4.50	6.75	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	34.82	17.75	2.44	7.32	5.96	12.33	2.44	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	26.19	15.41	1.54	4.11	4.62	6.16	3.59	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.88	13.06	3.18	4.59	5.29	7.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	8.66	0.67	3.33	4.66	5.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.68	17.32	2.55	6.62	7.13	7.64	2.55	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.08	15.21	1.60	4.00	4.00	9.07	3.74	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.48	18.52	2.46	4.91	6.05	8.69	1.32	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	38.65	20.25	1.23	5.52	4.29	10.43	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	37.51	17.12	4.89	4.08	8.15	8.97	4.89	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	24.16	14.79	3.96	4.37	6.46	7.29	1.67	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	22.70	13.45	1.12	3.92	5.04	6.73	3.08	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	38.12	19.58	1.03	7.21	5.15	12.36	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.39	12.77	3.77	6.97	3.48	6.68	2.90	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.51	9.86	1.49	5.68	3.89	7.17	2.39	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	18.26	9.96	3.32	3.87	7.75	7.19	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	39.59	18.73	2.12	2.83	7.42	12.02	5.66	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.34	17.33	4.43	3.69	6.64	6.64	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	24.18	2.30	1.15	3.45	10.36	5.76	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.78	16.50	3.84	4.99	9.59	8.06	3.07	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.04	11.32	3.96	3.40	2.83	5.66	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	10.67	0.82	4.92	4.92	4.92	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.73	16.27	2.71	5.42	3.62	7.68	2.71	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	15.80	1.44	7.18	2.87	7.90	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	14.94	2.24	1.49	5.23	9.71	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.53	12.63	3.72	4.46	7.43	4.83	1.49	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.25	11.63	1.72	3.02	6.03	8.18	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.11	15.41	3.43	0.86	4.28	10.28	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.65	13.33	3.00	5.33	6.33	7.00	1.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	34.39	12.07	1.21	6.64	6.64	7.84	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	9.95	1.42	2.84	5.69	6.40	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	36.78	12.03	2.41	4.47	5.50	6.53	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.84	16.10	1.61	3.76	8.59	7.51	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	22.22	5.39	1.35	3.37	6.06	2.69	2.02	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.37	16.67	2.22	3.33	4.07	6.30	2.96	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	15.12	1.16	6.98	3.49	3.49	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	11.64	3.17	5.29	4.23	5.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.01	13.20	3.20	8.00	5.20	6.00	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.80	16.72	1.45	5.81	8.72	8.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	30.66	16.86	2.30	8.43	3.07	11.50	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	33.54	12.33	1.48	7.89	10.36	11.35	2.47	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	36.70	10.35	0.94	4.70	1.88	14.11	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	41.73	18.10	3.52	4.02	8.05	14.08	4.53	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	28.84	19.83	3.15	10.36	6.76	8.11	4.51	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	56.80	22.37	0.00	12.05	10.33	15.49	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	45.42	16.92	4.01	8.02	7.57	18.70	8.02	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	47.31	22.29	3.52	4.30	10.17	20.72	1.96	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	42.88	19.79	2.64	3.96	5.94	19.13	7.92	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	44.63	20.76	2.08	7.26	6.23	16.61	5.19	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	48.13	26.69	2.19	6.13	7.00	11.38	5.69	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	40.26	26.84	1.12	6.15	3.35	16.77	6.71	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.95	28.27	3.09	6.18	7.07	21.64	6.62	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	45.90	22.76	4.63	5.79	6.94	19.67	6.17	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	52.15	32.91	5.57	5.57	12.15	26.33	7.09	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	50.95	32.68	3.36	6.73	8.65	28.84	7.21	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	39.36	25.84	3.58	10.34	6.36	23.06	6.36	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	46.79	40.71	3.65	8.51	10.94	28.56	7.90	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	35.97	28.36	3.46	8.30	6.23	32.51	5.53	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.06	39.14	5.32	9.12	11.40	33.06	6.84	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	36.15	34.60	2.58	6.71	10.84	20.14	6.71	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.07	35.67	3.02	2.42	7.26	33.86	4.84	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	43.42	25.04	2.85	7.61	6.97	19.33	6.02	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.91	29.85	4.26	5.33	6.40	24.52	7.46	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.58	28.73	4.02	8.05	4.02	18.96	4.60	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	47.31	29.83	4.11	7.71	8.23	21.08	7.71	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.90	19.81	2.83	7.07	7.78	15.56	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	26.67	3.97	2.84	6.81	19.86	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	40.77	17.06	3.33	6.66	7.07	15.39	3.33	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	31.32	21.93	3.92	5.48	10.18	18.01	3.13	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.97	20.04	3.34	9.60	4.18	12.11	2.09	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	40.42	17.66	0.93	6.50	4.65	10.22	4.18	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	27.43	16.73	2.01	6.02	6.69	9.37	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	22.45	17.64	3.74	12.83	11.23	11.76	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	39.60	20.61	2.02	11.72	6.47	9.29	2.42	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	40.38	13.77	6.42	10.10	9.18	8.26	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	15.11	1.78	10.67	6.22	11.56	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	41.60	22.22	4.56	7.41	5.70	17.67	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	43.71	16.87	2.30	5.37	6.14	9.97	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	25.72	14.23	2.74	4.38	4.92	8.75	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	34.30	15.59	4.45	7.57	15.15	7.57	1.78	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	45.75	21.58	3.38	7.80	10.14	12.74	0.52	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	30.50	20.56	3.98	10.61	6.63	12.60	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	14.55	6.24	10.39	6.24	12.47	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	2.96	0.46	1.60	2.73	1.14	0.23	0.23	0.91
Macrophage - monocyte derived, donor2	11313-117C8	2.75	1.28	3.85	1.65	0.92	0.18	0.18	0.55
Macrophage - monocyte derived, donor3	11389-118C3	4.33	1.84	2.62	1.97	1.05	0.26	1.05	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	4.78	0.00	0.53	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.24	12.68	1.27	1.90	1.27	1.11	1.90	0.32
Mallassez-derived cells, donor3	11930-125I4	5.84	5.00	1.53	1.53	1.81	1.25	0.83	0.28
Mammary Epithelial Cell, donor1	11273-116H4	3.59	5.88	1.30	1.49	2.89	0.80	0.10	0.30
Mammary Epithelial Cell, donor2	11350-117G9	3.19	2.61	1.16	1.74	2.90	0.00	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	3.24	2.99	0.25	3.24	2.74	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	6.10	23.05	2.03	1.36	2.71	9.49	1.36	0.00
Mast cell, donor1	11563-120D6	5.84	1.73	5.84	2.81	3.89	0.65	0.11	1.08
Mast cell, donor2	11565-120D8	66.57	13.97	40.12	13.67	29.72	14.56	1.78	10.10
Mast cell, donor3	11566-120D9	47.05	6.75	36.02	21.39	22.51	6.08	2.03	5.85
Mast cell, donor4	11567-120E1	73.75	12.76	31.56	11.52	26.06	18.62	2.30	9.22
Mast cell, expanded and stimulated, donor5	11940-126A5	7.43	1.22	4.21	4.77	1.55	0.33	0.11	1.89
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	2.92	11.09	7.00	1.75	2.33	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	3.90	2.75	5.62	2.98	2.98	0.23	0.11	1.38
Mast cell, expanded, donor8	11941-126A6	12.89	4.85	9.04	5.36	4.35	1.00	0.50	1.67
Melanocyte - dark, donor1	11502-119F8	2.69	0.60	1.39	0.80	0.20	0.00	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	3.46	1.38	0.35	1.04	0.00	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	6.16	1.96	0.87	1.09	1.81	0.43	0.07	0.22
Melanocyte - light, donor1	11274-116H5	2.82	0.71	0.24	1.65	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.92	2.73	0.68	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	10.41	2.60	0.00	2.60	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	5.21	1.35	0.21	1.56	0.52	0.10	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	7.80	0.54	0.54	1.88	1.34	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	5.62	0.80	1.07	2.14	0.27	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	7.32	3.97	2.85	3.35	1.86	0.25	0.25	0.99
Meningeal Cells, donor2	11573-120E7	10.56	5.72	3.08	0.88	0.88	1.32	0.44	0.88
Meningeal Cells, donor3	11654-122E7	4.73	3.59	2.36	2.36	1.39	0.41	0.41	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	2.85	3.99	0.86	2.57	0.57	0.29	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	4.43	5.53	1.41	1.71	1.01	0.20	1.31	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	5.23	1.31	0.00	0.00	0.00	1.31	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	4.31	4.31	0.72	0.72	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	5.51	1.69	1.06	1.91	0.42	0.00	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	3.02	5.03	0.50	1.01	0.50	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	6.81	2.86	0.88	2.64	1.32	1.32	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	7.31	0.73	1.46	0.73	1.46	0.00	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.16	6.75	1.64	1.64	0.41	1.02	1.64	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4.43	15.93	1.94	0.42	2.49	0.69	2.22	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	2.23	2.97	0.74	0.37	0.00	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	5.13	5.00	2.50	1.71	1.32	0.00	0.39	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	3.86	1.78	0.59	1.19	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	2.34	0.00	0.00	2.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.33	5.12	1.28	3.84	1.28	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	2.13	1.42	2.13	0.35	1.77	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	4.69	4.69	2.19	0.31	0.94	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	0.73	0.73	0.00	1.45	2.18	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	7.42	6.89	1.33	0.80	1.33	1.06	2.39	0.27
Mesothelial Cells, donor2	12156-128G5	5.51	6.51	0.50	0.50	1.00	1.00	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	7.15	7.88	2.02	1.16	1.73	1.45	2.53	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	5.40	4.05	1.35	2.70	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	3.69	1.48	4.93	1.23	0.49	0.25	1.23	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.24	2.94	3.53	2.94	0.00	0.00	1.47	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	10.37	10.37	0.00	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	2.48	0.93	0.93	1.86	1.55	0.62	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.32	1.66	1.87	0.41	0.21	1.04	0.62	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	4.63	2.32	2.32	2.32	0.00	0.00	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	4.25	2.75	3.25	2.25	0.25	0.25	1.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.79	4.65	2.33	1.40	0.93	0.00	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	2.03	0.81	2.44	1.63	0.61	0.41	1.02	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.75	2.77	3.56	1.58	0.40	0.00	1.58	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	8.55	0.00	34.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	0.88	2.65	1.77	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.80	1.52	1.14	1.14	0.38	0.00	1.90	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	11.84	2.63	0.00	3.95	0.00	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.79	1.49	4.03	1.06	0.42	1.27	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	2.76	2.76	0.00	0.00	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.86	3.87	1.49	0.00	0.30	1.79	1.49	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	5.03	1.68	0.00	0.00	0.00	1.68	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.52	3.76	2.26	1.00	0.50	2.51	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.37	3.33	2.38	0.95	0.48	0.48	1.19	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	13.82	4.98	0.55	4.42	0.55	1.11	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.45	3.91	3.22	1.15	1.15	1.61	1.61	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.05	2.73	4.21	0.84	0.84	1.89	1.26	1.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.40	4.89	3.87	0.61	1.22	2.85	1.63	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.65	2.36	2.79	1.07	0.43	1.07	1.50	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.89	2.89	3.78	0.44	0.22	1.78	1.11	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	30.96	10.32	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	3.94	2.19	0.88	1.10	1.31	0.44	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	4.56	1.52	0.51	1.01	2.03	0.51	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	21.54	0.00	1.66	11.60	0.00	3.31	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	5.98	3.26	0.54	0.27	0.82	2.17	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	5.00	2.35	0.29	1.47	1.18	2.06	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	11.99	7.63	0.00	7.63	1.09	2.18	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.77	3.84	2.88	0.96	0.96	0.48	2.40	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.81	5.60	4.80	1.20	2.00	2.40	3.20	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	26.05	4.11	1.37	6.86	0.00	0.00	4.11
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	5.01	3.50	0.00	0.50	3.00	0.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	28.54	6.12	0.00	10.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.32	7.44	5.26	0.44	0.88	2.19	2.63	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	18.76	0.00	1.10	6.62	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	32.02	6.40	0.00	7.68	0.64	1.92	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.69	6.69	3.72	1.98	2.23	1.74	1.49	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	7.65	5.57	0.70	2.78	0.70	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	39.78	6.63	0.00	15.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.13	5.47	3.08	2.39	2.74	1.03	0.68	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	10.94	5.69	0.00	3.06	0.88	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	30.54	7.10	1.78	6.04	1.07	0.71	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	8.70	1.40	1.96	1.40	1.40	1.40	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	7.07	3.33	1.25	1.66	2.91	0.83	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	25.06	2.91	0.58	9.32	0.58	0.00	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.86	3.92	3.32	1.81	2.11	0.60	1.51	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.51	5.43	3.34	6.26	2.09	0.42	2.92	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	57.75	7.22	7.22	28.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	7.39	9.24	0.92	2.77	0.92	0.92	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	6.83	3.41	3.41	2.28	1.14	2.85	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.77	11.61	4.97	2.21	3.45	0.69	1.52	1.52
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.70	3.37	3.37	1.81	1.55	1.04	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.58	8.15	5.15	2.14	0.86	1.29	1.72	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	26.04	3.18	0.64	8.26	0.00	0.64	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.67	8.54	6.41	1.60	4.27	0.80	2.40	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.29	6.29	5.69	2.99	2.39	0.60	1.20	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.80	7.91	5.23	1.27	1.13	0.85	0.85	1.41
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	7.33	2.23	2.23	1.27	0.32	1.27	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.64	7.52	5.09	1.33	1.99	0.22	1.11	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.93	14.03	3.41	1.52	3.79	0.38	3.79	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.82	9.38	3.98	0.57	2.84	0.85	1.70	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	5.41	3.69	2.21	0.98	0.74	1.97	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.91	19.55	3.91	0.65	6.52	0.00	1.30	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.06	6.17	3.53	2.65	0.88	0.59	0.29	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.78	3.17	3.75	1.44	0.58	0.58	2.31	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.66	7.42	2.47	1.24	1.65	0.82	2.89	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.55	10.12	4.47	1.19	2.98	1.19	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.29	0.33	1.31	1.31	0.33	0.00	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	0.00	0.00	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.57	0.00	3.56	0.99	0.59	0.59	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	0.93	5.59	0.93	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.50	0.38	2.63	0.38	0.38	0.00	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.13	1.33	1.07	0.80	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.92	0.68	2.38	1.92	0.90	0.23	0.79	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	0.00	2.21	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1.83	0.73	0.00	1.83	0.37	0.37	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	1.56	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.74	1.60	3.21	1.60	0.53	2.14	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	1.01	2.02	1.01	0.00	1.01	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.53	0.84	2.95	0.00	0.00	0.42	0.42	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	19.07	2.72	0.00	4.09	1.36	23.15	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	1.27	6.99	0.64	0.00	0.64	2.54	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	11.34	5.67	0.00	0.00	4.86	8.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	6.04	9.06	4.53	3.02	0.00	7.55	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	154.17	22.84	11.42	22.84	0.00	51.39	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	78.30	19.57	9.79	3.26	0.00	39.15	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	28.51	0.00	0.00	4.75	4.75	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	100.39	0.00	0.00	0.00	25.10	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	5.39	2.15	2.15	0.65	0.43	0.43	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.88	1.57	0.52	1.57	0.52	1.05	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.67	1.33	4.00	0.67	0.67	0.00	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.17	9.60	1.67	1.25	0.83	1.25	2.92	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.42	12.36	5.32	3.23	3.61	0.19	0.38	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	15.96	1.60	0.00	6.38	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	2.04	2.04	0.68	0.68	0.68	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	5.51	7.35	3.68	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	3.35	1.26	0.42	0.00	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.76	11.85	1.16	0.46	0.93	0.46	2.79	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.30	5.13	2.43	1.62	0.27	0.54	1.62	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.94	6.10	1.68	0.21	1.26	1.05	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.96	2.98	0.50	0.50	1.49	2.48	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.50	6.77	2.44	0.27	1.08	0.00	1.08	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.12	6.80	1.13	1.13	1.59	0.23	2.49	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.12	7.02	2.78	0.65	0.49	1.31	1.47	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.30	5.29	2.00	1.82	1.28	0.73	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	3.18	0.53	2.12	1.59	1.59	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	1.80	3.60	0.60	3.60	1.80	1.80	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.17	10.17	3.61	1.64	0.66	0.00	1.31	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.02	7.32	1.30	1.46	0.98	0.81	3.74	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.23	6.17	2.47	1.94	1.76	0.35	0.35	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	3.52	2.81	1.41	0.70	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	6.90	0.46	0.46	1.84	2.30	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.75	3.21	2.25	0.96	0.32	0.32	2.25	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.62	17.93	4.83	1.72	1.03	0.69	4.14	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	22.76	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	9.80	1.34	2.01	2.23	0.45	1.11	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.85	11.01	1.69	0.85	2.12	0.85	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.60	11.16	0.71	1.42	1.42	0.24	1.90	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	4.72	1.29	2.15	1.29	1.29	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	27.08	9.03	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.00	8.66	5.66	2.33	1.00	1.00	1.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.57	9.47	2.25	2.71	0.90	1.35	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	8.73	1.59	0.40	1.59	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	4.64	2.79	0.00	0.93	2.79	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.22	8.32	3.03	0.76	1.89	0.38	3.03	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.78	6.84	2.61	1.63	1.30	3.26	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.59	6.10	5.67	2.18	1.74	1.31	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.31	10.85	3.62	2.26	5.43	1.81	2.26	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	7.06	0.88	2.65	0.00	0.88	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.98	4.65	0.00	1.99	1.33	1.33	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	2.48	1.49	3.47	2.48	1.98	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.02	10.34	2.30	0.38	1.53	3.83	3.06	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.31	7.56	3.63	1.81	2.42	0.60	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.49	9.95	3.09	1.99	1.11	2.87	0.88	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	6.78	0.00	2.71	0.68	3.39	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	5.11	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	7.32	2.44	0.00	0.61	1.83	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.05	10.07	4.09	1.89	1.26	0.63	2.52	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.04	8.78	2.42	1.82	0.91	1.82	1.51	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	4.75	1.58	1.58	1.58	1.58	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	26.07	7.94	3.40	2.27	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	5.06	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	3.23	3.48	0.75	0.37	0.75	0.25	0.75	0.12
Myoblast, donor2	11322-117D8	5.37	2.69	2.30	2.49	1.73	0.38	0.77	0.00
Myoblast, donor3	11398-118D3	7.06	2.19	1.68	1.51	1.35	1.68	0.67	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	3.50	1.61	3.21	1.46	2.77	0.00	5.55	0.15
Natural Killer Cells, donor1	11230-116C6	23.37	1.85	38.44	8.00	6.46	3.38	22.14	14.15
Natural Killer Cells, donor2	11311-117C6	20.81	3.02	41.61	20.81	5.73	2.11	22.01	15.08
Natural Killer Cells, donor3	11387-118C1	28.16	3.13	30.92	16.56	4.97	3.50	17.30	11.78
Neural stem cells, donor1	11275-116H6	11.25	4.36	2.54	2.54	6.17	1.09	0.36	0.73
Neural stem cells, donor2	11352-117H2	13.48	7.70	0.00	1.93	0.00	1.93	0.00	1.93
Neurons, donor1	11494-119E9	26.17	3.41	4.55	3.41	0.00	3.41	0.00	0.00
Neurons, donor2	11574-120E8	10.79	3.08	1.54	3.74	1.10	0.22	0.44	0.44
Neurons, donor3	11655-122E8	18.91	1.64	0.00	0.82	0.00	0.00	2.47	0.00
Neutrophils, donor1	11233-116C9	70.53	7.42	16.70	11.14	12.99	5.57	12.99	4.64
Neutrophils, donor2	11314-117C9	75.37	11.60	20.29	8.70	8.70	14.49	26.09	11.60
Neutrophils, donor3	11390-118C4	98.35	26.88	30.54	7.33	11.00	2.44	27.49	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	4.75	3.44	0.83	1.19	2.49	0.24	0.59	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	4.23	2.28	0.98	0.98	1.30	0.33	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.01	3.21	1.20	1.40	1.00	0.80	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	3.72	1.79	0.14	0.83	1.38	0.41	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	4.20	2.75	0.14	2.17	1.01	0.00	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	7.04	4.54	1.14	0.57	0.79	0.79	0.45	0.45
Olfactory epithelial cells, donor4	11936-126A1	6.92	2.24	0.68	1.66	2.34	0.19	0.19	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	9.03	10.83	0.60	0.00	1.20	1.20	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.53	6.81	1.28	1.91	2.13	1.06	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	2.29	1.14	0.00	1.14	1.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	1.24	2.48	0.00	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.28	3.71	2.15	0.78	1.56	0.20	1.17	0.20
Osteoblast, donor2	11354-117H4	8.43	5.62	2.11	2.11	0.70	0.00	2.11	0.00
Osteoblast, donor3	11426-118G4	14.57	8.35	3.20	3.38	1.78	0.71	0.89	0.71
Pancreatic stromal cells, donor1	11249-116E7	6.82	9.52	2.78	1.60	1.01	0.34	1.35	0.08
Pericytes, donor1	11491-119E6	4.23	2.67	1.22	1.78	0.78	0.11	0.11	0.45
Pericytes, donor2	11571-120E5	6.34	4.75	3.17	2.72	2.26	0.23	0.68	0.23
Pericytes, donor3	11652-122E5	8.95	13.43	2.03	1.63	2.24	1.02	1.83	0.41
Perineurial Cells, donor1	11499-119F5	4.52	2.03	1.36	1.36	1.02	0.57	0.34	0.34
Perineurial Cells, donor2	11579-120F4	3.96	1.10	0.74	1.56	1.01	0.28	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.82	2.87	17.85	10.52	8.29	1.91	10.84	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.20	6.86	13.22	14.94	3.92	2.45	12.49	7.59
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	36.11	4.53	19.54	12.94	5.05	10.22	16.05	9.19
Placental Epithelial Cells, donor1	11278-116H9	7.65	2.63	0.96	0.72	1.20	0.72	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	2.22	6.65	2.22	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.09	1.96	0.20	1.18	1.37	0.20	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.59	5.06	2.53	0.95	0.63	1.27	1.58	0.00
Preadipocyte - breast, donor1	11467-119B9	6.38	4.13	1.88	1.69	0.94	0.94	0.75	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.01	20.23	4.31	2.22	4.83	1.96	7.05	0.65
Preadipocyte - breast, donor2	11328-117E5	10.36	12.83	2.70	4.05	1.13	2.25	2.93	0.23
Preadipocyte - omental, donor1	11468-119C1	4.80	2.34	2.77	1.28	1.17	0.96	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	7.86	11.35	2.62	1.75	0.87	0.44	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	6.73	3.72	1.86	2.01	1.72	0.57	1.00	0.72
Preadipocyte - perirenal, donor1	11469-119C2	3.94	1.97	1.97	3.94	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2.76	2.15	2.46	1.23	1.23	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	7.44	3.90	2.12	1.77	1.77	0.18	1.77	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	3.92	0.51	2.04	0.85	0.17	0.17	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	3.17	3.35	2.70	2.42	1.49	0.47	0.65	0.47
Preadipocyte - visceral, donor2	11357-117H7	6.90	2.76	2.30	1.84	0.46	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	3.55	2.93	2.09	1.46	0.42	0.52	0.52	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	15.09	3.17	2.26	3.77	2.11	0.60	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	11.78	14.62	2.03	1.35	2.57	4.47	5.82	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.49	2.02	0.55	1.16	0.92	0.86	0.37	0.00
Prostate Stromal Cells, donor1	11254-116F3	5.70	5.58	2.05	2.16	1.03	0.91	0.57	0.91
Prostate Stromal Cells, donor2	11332-117E9	10.58	10.04	3.41	3.41	1.61	1.08	0.72	1.43
Prostate Stromal Cells, donor3	11405-118E1	8.13	5.63	1.98	1.25	1.67	0.10	1.15	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	2.92	1.46	0.36	1.46	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.94	8.87	2.15	1.73	2.36	0.76	1.32	0.69
Renal Epithelial Cells, donor1	11517-119H5	7.10	7.61	4.57	1.01	3.04	0.51	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	4.98	1.42	2.13	0.71	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	10.16	5.82	2.75	2.22	1.27	0.95	0.64	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	2.04	2.04	2.04	1.36	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.66	4.99	1.21	1.89	0.67	0.27	0.67	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	7.33	4.22	4.22	3.11	2.00	0.67	0.67	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	1.33	2.66	1.33	0.67	0.67	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	4.62	5.50	1.54	2.64	0.66	0.66	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	14.42	6.27	1.25	0.00	2.51	0.63	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	5.55	4.44	0.55	0.55	0.55	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.59	3.49	4.56	1.61	1.88	1.34	0.27	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.06	3.37	0.84	0.42	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.61	5.01	2.51	1.74	2.51	0.77	0.39	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.22	7.00	1.81	2.85	1.56	0.52	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.10	9.66	3.41	1.14	1.71	0.57	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	7.20	2.06	4.12	2.06	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	2.76	0.50	1.25	1.51	0.75	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.17	5.61	4.01	4.81	4.28	1.34	0.94	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	12.51	0.89	3.57	6.25	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.57	4.95	1.65	4.40	1.65	2.20	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.04	10.44	5.80	8.12	4.06	2.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.67	8.97	3.64	6.76	1.43	1.95	0.26	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.63	9.24	2.09	5.66	1.79	2.58	0.60	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.98	8.92	3.90	5.58	3.35	2.68	0.11	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.96	6.70	2.98	6.95	1.61	2.36	0.87	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.52	5.94	4.20	6.76	2.45	1.86	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	32.82	9.48	4.16	8.32	4.16	2.31	0.69	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	20.67	8.08	3.83	5.75	1.51	2.19	0.41	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	27.53	8.77	3.63	4.54	1.82	2.12	1.06	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	28.49	8.60	3.58	3.58	3.23	3.23	0.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.38	7.89	2.44	8.03	2.01	2.30	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	20.18	6.65	2.58	4.61	1.93	2.90	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	25.67	8.41	2.88	4.87	2.66	4.65	1.55	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.53	5.74	3.63	3.44	1.91	3.25	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.61	6.99	3.63	5.78	2.79	2.14	0.56	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.94	7.52	4.70	4.32	2.82	3.19	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.78	10.35	3.05	3.98	1.99	1.73	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.07	5.16	3.60	3.80	1.46	2.34	0.29	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.25	6.49	2.86	6.68	1.72	1.15	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.37	7.69	3.10	4.49	2.56	1.50	0.64	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	18.50	5.33	3.64	5.61	3.92	3.36	0.56	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	25.63	9.40	3.76	5.13	2.05	2.39	0.51	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	17.50	10.39	3.83	3.83	2.73	2.19	0.73	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.05	5.89	3.19	5.03	2.21	2.45	0.00	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.94	9.40	3.22	5.78	2.55	2.69	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.58	9.91	4.72	6.13	3.30	1.42	0.00	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.02	5.56	2.18	4.76	0.60	1.79	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.02	7.72	3.74	7.02	1.87	1.40	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	21.56	10.58	6.22	3.73	1.66	3.32	0.83	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.69	5.97	4.65	9.07	3.54	2.21	0.44	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.86	8.98	4.18	5.85	1.88	2.92	0.42	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	23.15	7.67	2.83	5.25	2.29	2.69	0.40	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.09	10.05	3.58	4.09	2.55	0.68	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	29.30	16.00	6.36	6.56	4.63	2.51	0.58	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	23.56	6.71	3.61	4.99	2.24	2.06	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.18	14.40	4.80	4.39	2.61	1.78	0.69	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.24	10.18	4.60	5.91	3.61	2.63	0.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	22.16	5.28	2.90	5.11	1.70	1.70	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.49	4.88	2.66	4.88	3.40	1.63	0.59	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.99	10.93	4.26	6.93	2.13	2.67	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.78	3.87	2.49	7.74	2.63	2.49	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	26.43	5.00	1.43	5.71	1.43	2.38	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.67	6.05	3.63	5.84	2.22	3.43	0.20	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.89	4.99	2.73	4.14	1.41	0.94	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	33.89	9.08	4.89	5.94	2.79	4.54	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.31	10.28	2.42	7.56	4.23	2.72	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.50	5.63	2.94	5.39	1.22	1.10	0.12	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	61.71	15.57	6.70	11.35	5.97	6.11	1.02	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.81	6.69	1.83	3.65	4.87	3.65	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.97	6.33	2.41	4.82	1.81	1.21	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.23	7.01	5.20	5.88	5.20	4.07	0.45	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.73	5.39	2.40	6.89	3.89	3.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	31.88	8.74	4.60	7.08	4.01	3.42	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.65	7.90	5.12	6.83	5.98	5.12	1.49	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	49.88	10.22	6.61	4.21	7.81	1.20	1.20	0.00
Schwann Cells, donor1	11498-119F4	6.21	4.14	2.63	3.39	0.38	0.38	0.19	0.38
Schwann Cells, donor2	11578-120F3	0.00	0.00	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.67	4.60	1.97	3.07	1.31	1.31	0.44	0.00
Sebocyte, donor1	11220-116B5	8.76	4.93	1.10	0.55	1.10	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	6.43	3.68	0.00	1.84	0.00	0.92	0.46	0.46
Sebocyte, donor3	11378-118B1	4.33	0.82	0.62	0.82	0.62	0.62	0.21	0.00
Sertoli Cells, donor1	11255-116F4	4.97	0.00	1.66	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	0.00	0.00	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	5.10	1.50	1.32	2.64	1.06	0.09	0.09	0.35
Skeletal Muscle Cells, donor2	11358-117H8	3.61	2.89	0.00	2.89	1.45	0.72	0.72	1.45
Skeletal Muscle Cells, donor3	11430-118G8	9.20	3.34	1.67	6.69	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	5.03	7.70	2.83	2.20	2.04	0.16	0.63	0.31
Skeletal Muscle Cells, donor5	11455-119A6	5.65	3.27	2.23	3.42	1.19	0.59	0.89	0.59
Skeletal Muscle Cells, donor6	11459-119B1	7.85	7.70	3.69	2.62	2.62	0.00	0.46	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	3.53	3.78	2.90	2.27	1.76	0.13	0.50	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	5.28	5.56	2.28	2.00	1.71	0.57	0.86	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.55	6.05	3.77	3.08	2.48	0.89	1.09	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.33	2.70	1.43	2.19	1.18	0.84	0.17	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	6.51	3.62	2.17	0.72	2.90	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.50	5.23	0.69	2.06	1.38	0.55	0.55	0.55
Skin - palm, donor1	10286-104F7	13.43	8.06	0.00	5.37	26.86	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.75	5.19	0.72	1.87	1.73	1.73	0.86	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	34.35	26.17	7.36	5.73	11.45	6.54	3.27	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.71	3.12	1.04	1.56	0.78	0.52	0.65	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	5.56	5.28	0.83	1.25	2.09	0.97	1.11	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	6.33	5.20	0.98	1.69	1.13	0.56	0.42	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.60	18.82	5.92	6.34	6.13	3.81	3.81	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	8.62	2.40	1.12	2.62	2.17	0.75	0.45	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.39	0.62	1.85	2.16	0.31	0.31	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.00	3.56	1.78	2.67	1.56	1.33	1.11	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	2.94	1.18	1.76	1.76	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.08	1.10	0.88	0.66	0.88	0.00	0.88	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.76	3.94	1.18	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	2.32	0.77	1.55	2.32	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	4.00	0.00	1.00	1.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.46	0.93	1.33	1.06	0.27	0.27	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	2.22	1.99	1.33	0.89	0.89	0.22	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.10	4.10	0.64	1.02	0.90	0.26	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.56	6.19	2.28	0.33	1.95	0.33	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.97	12.99	1.77	1.18	1.18	1.18	2.95	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.83	21.35	2.28	0.71	4.13	2.85	5.84	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.02	11.88	1.95	0.81	2.28	0.81	1.79	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.13	7.92	1.83	1.83	2.74	0.00	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.05	1.77	2.27	2.27	1.26	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	1.91	0.48	0.48	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	5.16	9.73	1.92	0.29	0.74	0.15	2.21	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	6.46	10.12	4.09	1.72	2.37	0.43	1.51	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.03	9.45	2.10	2.62	2.52	0.21	2.20	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.56	2.63	1.08	1.08	1.08	0.93	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	2.16	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2.99	1.79	0.00	0.60	1.20	0.00	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.88	8.53	3.07	2.39	1.02	1.02	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	4.40	2.67	1.10	1.65	1.02	0.08	0.16	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	3.82	3.02	1.51	1.91	1.21	0.60	0.70	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	5.01	2.96	1.14	1.59	0.23	0.23	0.23	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	3.02	1.21	2.42	1.21	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	5.30	8.74	5.03	1.06	4.50	2.38	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.73	7.32	3.86	2.00	1.73	0.40	0.93	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	9.89	5.38	2.50	1.63	0.88	1.25	1.13	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1.52	3.04	1.78	0.25	0.76	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	4.82	4.37	2.56	1.66	1.21	0.75	0.60	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	0.75	0.75	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	23.26	1.29	3.88	3.88	5.17	2.58	2.58	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.05	1.86	0.00	0.93	0.93	0.00	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	1.51	2.02	1.01	0.50	0.00	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	2.19	1.88	1.57	0.63	0.31	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	7.08	0.59	0.29	1.18	0.00	1.18	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	3.33	3.42	3.42	1.08	1.50	0.50	0.33	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	1.40	2.34	0.93	1.40	1.40	0.00	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.30	1.44	0.86	0.86	0.72	0.00	0.43	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.10	3.57	1.27	2.80	0.00	0.00	1.78	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.01	2.07	0.75	1.32	0.38	0.75	1.13	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	5.87	12.02	2.93	1.54	2.10	0.84	1.54	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.11	7.29	1.09	1.34	0.84	0.08	0.84	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	5.24	0.48	0.95	1.43	0.95	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2.20	2.45	1.47	0.49	0.24	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.08	9.50	2.43	1.99	1.33	0.66	2.21	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.10	5.85	0.59	2.05	1.17	0.29	0.59	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.22	2.53	1.94	1.17	0.97	0.19	0.39	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.44	11.64	1.85	0.79	0.53	1.85	1.59	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.09	2.60	2.23	1.49	1.86	0.37	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.83	18.69	3.59	1.08	2.87	2.52	3.95	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.11	10.79	1.70	1.42	3.12	1.70	2.56	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.51	5.51	1.18	0.79	1.18	1.18	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	4.06	4.06	0.76	0.51	1.02	0.25	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	2.80	4.79	1.60	0.80	2.00	0.40	1.20	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	4.60	4.60	2.51	0.84	1.25	0.42	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	7.33	5.96	4.13	0.46	0.46	1.38	0.46	0.92
Synoviocyte, donor1	11291-117A4	8.75	4.71	1.85	1.35	1.35	1.18	0.67	0.17
Synoviocyte, donor2	11368-117I9	4.36	0.84	0.67	0.50	0.34	0.34	1.01	0.17
Synoviocyte, donor3	11440-118H9	1.56	0.67	0.22	1.56	0.89	0.67	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	7.86	7.50	3.22	1.43	1.43	0.36	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	1.98	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.64	6.48	2.55	2.55	1.85	0.69	0.46	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	3.73	2.87	0.93	1.15	1.79	0.29	0.57	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	7.34	2.71	1.93	1.93	0.77	0.39	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	2.86	0.00	1.72	0.00	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.21	6.27	5.04	2.95	6.15	2.34	0.62	0.37
Urethra, donor2	10319-105A4	10.79	0.00	1.80	3.60	10.79	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.64	7.44	1.06	1.86	3.19	0.27	1.86	0.80
Urothelial Cells, donor2	11600-120H7	5.21	6.81	0.80	1.20	1.60	0.80	0.80	0.00
Urothelial Cells, donor3	11681-122H7	6.19	5.96	0.92	0.23	1.38	0.69	1.15	0.46
Urothelial cells, donor0	11216-116B1	5.80	8.02	2.01	1.56	3.57	0.00	1.56	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	0.89	4.45	2.67	5.34	0.00	4.45	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	0.00	2.86	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.90	0.68	1.37	2.74	0.00	2.05	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.89	0.00	4.82	4.48	3.10	0.69	0.34	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	9.88	0.58	7.55	4.07	2.32	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	9.37	2.08	4.16	3.12	3.12	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.01	1.84	3.67	5.51	2.75	0.92	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	0.00	0.91	1.83	2.74	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	6.41	5.80	2.59	1.60	1.85	0.86	1.23	0.62
Wilms' tumor cell line:HFWT	10597-108E3	3.52	6.16	0.88	0.00	2.64	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	17.60	1.68	0.84	3.91	1.40	0.00	1.40	0.28
achilles tendon, donor2	10292-104G4	12.40	10.33	2.07	4.13	10.33	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.10	0.00	2.55	4.84	1.27	0.51	0.76	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	2.79	0.00	2.32	2.55	1.39	0.70	1.86	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	11.28	0.47	5.22	6.89	1.66	1.90	1.07	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2.45	0.00	2.18	2.72	0.54	0.82	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3.65	0.56	0.56	4.22	0.00	0.56	0.28	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2.11	0.00	1.90	3.81	1.90	0.42	0.63	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.08	0.27	1.09	4.36	1.91	0.82	0.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.88	0.44	0.88	0.00	1.76	0.44	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	3.68	0.00	0.82	7.76	2.04	0.41	0.41	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	4.66	0.39	1.16	3.49	1.16	0.78	2.33	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.47	0.00	0.55	4.05	0.74	0.37	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	3.90	7.80	3.90	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1.39	0.70	1.16	3.72	1.16	0.46	0.46	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	3.62	0.00	0.52	2.07	1.04	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1.17	0.00	0.58	1.46	1.75	0.00	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	2.79	1.86	2.79	1.86	2.32	0.46	3.25	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	3.70	0.82	2.06	2.06	4.11	0.41	2.06	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.76	1.84	2.15	3.38	0.61	0.00	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	3.41	1.28	2.99	3.84	0.43	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.82	0.30	1.21	2.73	1.21	0.61	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.61	1.44	2.41	3.61	1.68	0.72	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.23	0.00	1.78	2.23	1.11	0.00	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.00	1.00	3.67	2.67	0.00	0.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	22.30	7.43	5.57	14.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.01	0.75	2.26	1.88	1.88	0.38	1.88	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.87	0.44	1.74	4.80	3.93	0.00	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	0.00	0.00	0.00	3.75	0.00	1.87	3.75
adenocarcinoma cell line:IM95m	10796-110I4	4.24	3.06	2.35	3.06	5.89	0.24	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	11.63	4.81	4.03	3.72	5.12	0.31	0.62	1.40
adipose, donor1	10184-103D4	18.77	0.59	2.35	14.07	3.52	1.17	0.00	0.00
adipose, donor2	10185-103D5	31.22	2.03	2.43	5.68	4.46	0.41	0.81	1.22
adipose, donor3	10186-103D6	23.69	1.91	5.45	8.99	2.18	1.63	0.00	0.27
adipose, donor4	10187-103D7	45.94	1.73	0.00	6.93	4.33	1.73	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.31	0.79	2.21	1.74	2.21	0.00	0.16	0.47
adrenal gland, adult, pool1	10081-102A9	7.28	0.00	3.64	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	3.07	1.87	2.80	1.60	4.14	0.13	1.20	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	3.93	8.93	3.57	2.86	3.57	0.00	1.43	1.07
amniotic membrane cells, donor1	12235-129G3	44.28	19.71	3.71	4.17	7.42	6.72	2.55	0.93
amniotic membrane cells, donor2	12236-129G4	17.92	3.72	2.70	2.37	4.06	1.35	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	27.69	17.09	1.18	2.36	5.30	3.54	3.83	0.00
amygdala - adult, donor10196	10167-103B5	9.49	4.74	2.37	1.19	3.56	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	23.32	4.26	3.85	6.49	3.65	1.22	0.81	0.81
amygdala, newborn, donor10223	10360-105E9	12.91	6.13	2.58	2.26	4.84	1.61	2.58	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	7.77	2.93	2.55	2.55	1.78	0.25	1.66	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	5.74	1.76	1.32	0.88	1.54	0.44	0.88	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	11.69	1.34	3.34	6.35	2.34	1.00	3.01	1.67
aorta, adult, pool1	10052-101G7	19.02	5.10	5.30	3.53	5.30	3.53	1.37	0.78
appendix, adult	10189-103D9	15.91	1.94	8.93	11.26	6.21	4.66	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	4.82	1.38	0.69	3.44	0.69	0.00	0.69	0.69
artery, adult	10190-103E1	12.23	6.79	2.72	8.15	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	20.86	12.46	4.35	5.50	4.20	0.72	1.01	0.87
b cell line:RPMI1788	10427-106D4	9.37	4.01	5.20	2.68	6.84	1.34	1.34	1.49
basal cell carcinoma cell line:TE 354.T	10702-109G9	7.77	7.77	2.22	2.22	0.55	1.11	1.66	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	9.82	7.84	2.98	1.29	2.08	0.60	1.19	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	6.03	1.67	0.84	2.18	3.01	1.34	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.91	0.56	1.68	2.24	1.12	0.56	0.00	1.68
bladder, adult, pool1	10011-101C2	14.12	6.63	5.76	5.54	8.04	1.52	0.33	0.76
blood, adult, pool1	10053-101G8	6.64	0.00	2.21	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	1.71	3.43	4.28	0.00	3.43	0.00	0.00	0.00
bone marrow, adult	10192-103E3	4.72	6.07	3.37	4.72	4.72	0.00	0.00	2.70
brain, adult, donor1	10084-102B3	13.33	3.08	4.10	9.23	7.18	3.08	2.05	2.05
brain, adult, pool1	10012-101C3	14.03	2.90	3.67	6.57	5.01	0.45	1.22	0.78
brain, fetal, pool1	10085-102B4	10.69	5.34	8.01	13.36	2.67	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.21	10.57	1.98	3.30	8.26	0.99	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	7.74	1.62	0.12	1.87	1.87	0.37	0.50	0.25
breast, adult, donor1	10080-102A8	15.15	1.26	0.63	2.53	1.26	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1.91	2.16	1.27	2.16	3.56	0.38	0.38	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	7.11	4.33	1.55	1.55	2.47	0.00	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.06	3.91	6.45	2.53	4.37	0.23	1.84	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.36	1.21	0.24	3.15	2.42	0.48	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.99	0.00	1.88	3.29	0.47	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	4.27	2.19	3.39	1.64	1.75	0.11	0.22	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	15.53	1.27	2.22	3.80	0.95	0.00	1.90	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	8.78	5.06	3.46	7.99	4.26	0.53	2.13	0.00
caudate nucleus - adult, donor10196	10177-103C6	14.97	11.51	6.91	6.91	5.76	2.30	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	19.91	2.84	2.68	4.85	1.84	1.51	1.00	0.50
caudate nucleus, adult, donor10258	10379-105H1	6.88	2.29	4.58	3.06	1.53	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	17.95	8.06	1.83	6.59	2.56	3.66	1.83	0.37
cerebellum - adult, donor10196	10173-103C2	17.48	0.00	2.91	20.39	14.57	5.83	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	36.08	2.99	4.48	19.86	3.63	2.99	0.85	0.00
cerebellum, adult, pool1	10083-102B2	11.73	1.72	1.03	4.83	3.45	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	15.78	2.49	1.66	9.96	5.81	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	20.68	8.57	6.05	7.06	5.80	1.76	1.26	0.50
cerebrospinal fluid, donor2	10294-104G6	5.12	4.39	0.00	4.39	3.65	0.73	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	5.61	0.14	0.00	3.45	0.86	0.43	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	15.58	6.30	1.82	2.32	4.81	1.82	3.98	0.50
cervix, adult, pool1	10013-101C4	17.01	6.19	5.25	6.51	6.40	1.47	0.73	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.78	7.25	3.20	0.98	2.65	0.84	1.39	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	26.13	2.61	0.00	9.14	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.12	5.84	1.86	4.35	3.36	1.86	1.12	0.87
choriocarcinoma cell line:SCH	10785-110H2	32.16	15.65	2.71	4.31	4.44	6.41	1.60	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	12.57	4.74	2.85	9.72	2.37	1.90	0.47	0.95
chorionic membrane cells, donor1	12238-129G6	23.93	10.54	2.85	2.85	4.56	5.98	1.99	0.00
chorionic membrane cells, donor2	12239-129G7	8.75	2.49	2.49	1.99	1.49	0.40	0.40	0.10
chorionic membrane cells, donor3	12240-129G8	14.29	8.24	5.49	4.95	1.65	2.75	1.65	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	0.00	4.04	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	3.07	1.15	0.77	0.96	1.73	0.58	1.34	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2.32	1.48	1.27	0.42	0.42	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	16.69	12.33	6.42	4.88	6.42	3.08	0.00	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	5.81	13.55	4.84	5.08	7.50	0.73	0.24	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	7.53	9.98	5.09	5.09	4.07	0.41	0.41	1.83
chronic myelogenous leukemia cell line:K562	10454-106G4	8.24	12.07	3.53	2.06	5.59	0.00	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	7.82	1.30	1.04	4.43	1.04	0.78	0.78	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	7.54	3.43	2.51	3.89	2.51	0.46	0.69	0.91
clear cell carcinoma cell line:TEN	10636-108I6	8.68	9.54	4.86	3.64	1.91	1.04	1.56	0.69
colon carcinoma cell line:CACO-2	10513-107D9	5.13	1.83	3.29	3.84	2.20	0.18	0.92	1.10
colon carcinoma cell line:COLO-320	10420-106C6	17.86	5.32	6.84	12.16	11.40	0.38	1.52	0.76
colon, adult, donor1	10082-102B1	5.95	1.19	0.00	4.76	4.76	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	11.87	1.76	5.64	5.29	7.87	0.94	0.35	0.71
colon, fetal, donor1	10070-101I7	15.45	3.71	1.24	3.09	5.56	0.00	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	36.67	27.50	36.67	4.58	13.75	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	16.15	1.70	2.55	5.10	2.97	3.82	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.32	0.45	1.96	4.08	1.36	1.51	0.30	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	1.83	0.56	1.83	1.83	1.83	0.99	0.00	0.42
corpus callosum, adult, pool1	10042-101F6	17.80	5.64	2.76	5.64	5.75	5.53	1.00	0.55
cruciate ligament, donor2	10295-104G7	16.21	8.92	6.48	3.24	12.97	2.43	2.43	1.62
diaphragm, fetal, donor1	10069-101I6	22.47	8.03	4.01	4.82	6.42	4.01	1.61	1.61
diencephalon, adult	10193-103E4	8.16	2.40	0.72	2.16	2.64	1.92	0.24	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.36	0.00	0.92	3.21	0.92	0.46	1.84	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	6.41	4.36	1.80	3.85	4.87	0.00	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.02	4.33	0.72	1.93	1.69	1.20	0.48	0.24
ductus deferens, adult	10196-103E7	9.97	1.50	1.50	3.99	3.49	1.50	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	1.44	1.44	1.44	1.44	2.88	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	12.51	4.41	5.89	8.83	8.83	2.21	0.00	2.21
dura mater, adult, donor1	10041-101F5	7.10	2.64	4.38	5.95	5.37	0.74	1.65	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	27.31	2.66	5.33	4.66	2.22	2.89	3.33	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.88	0.29	2.58	2.29	1.15	0.86	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	8.63	9.25	1.85	2.47	4.93	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	3.94	4.24	3.33	3.03	3.63	0.00	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	6.79	6.17	2.47	4.32	3.09	1.23	0.00	1.85
embryonic pancreas cell line:2C6	10603-108E9	3.94	10.51	3.94	3.94	3.94	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	15.75	12.07	6.70	7.04	2.01	3.02	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	7.79	1.45	2.17	1.63	1.81	0.36	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.31	0.80	0.32	0.80	1.29	0.64	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	9.23	4.34	1.33	4.00	4.78	0.56	1.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.03	4.51	1.10	1.54	2.75	0.88	1.10	0.00
epididymis, adult	10197-103E8	11.51	3.35	2.51	5.02	4.19	0.42	0.42	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.61	12.24	5.68	1.95	4.61	1.95	1.60	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.90	1.57	2.36	1.57	0.79	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	6.68	3.54	2.23	4.72	1.18	0.52	0.66	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	5.91	2.07	2.36	5.71	2.36	0.79	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.59	3.70	2.24	4.48	2.13	1.01	0.00	0.22
esophagus, adult, pool1	10015-101C6	11.47	5.84	3.19	4.25	4.35	0.96	0.96	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.39	1.25	1.88	1.88	1.63	0.25	0.13	0.38
eye - muscle inferior rectus, donor1	10272-104E2	2.41	7.24	2.41	2.41	12.07	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	10.52	4.21	2.10	2.10	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	8.93	2.98	1.49	7.44	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	4.59	9.17	5.73	1.15	9.17	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	39.35	5.83	2.91	13.12	4.37	4.37	0.00
eye, fetal, donor1	10054-101G9	14.75	4.07	2.03	4.32	4.32	0.25	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	4.62	6.15	3.21	2.56	2.69	0.38	1.80	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	4.04	5.22	2.14	1.42	3.09	0.47	1.66	0.24
frontal lobe, adult, pool1	10040-101F4	17.26	2.91	4.03	5.16	4.60	1.13	1.03	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	20.42	3.30	0.00	3.00	3.00	2.40	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.97	18.65	3.38	1.83	3.84	0.37	2.38	0.73
gall bladder, adult	10198-103E9	10.62	3.86	7.73	4.83	7.00	3.38	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	6.98	0.54	8.05	4.83	6.44	0.00	0.00	2.68
gamma delta positive T cells, donor2	11938-126A3	8.96	1.49	8.96	8.96	5.23	0.37	1.12	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	5.07	2.53	0.63	1.06	1.69	0.21	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.03	4.26	6.58	3.48	4.64	0.77	1.93	1.35
gastric cancer cell line:AZ521	10549-107H9	5.57	6.72	4.59	3.61	3.12	1.31	2.79	1.31
gastric cancer cell line:GSS	10560-108A2	2.75	0.00	1.83	3.66	3.66	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.08	5.03	4.11	14.16	1.83	1.83	0.69	0.69
giant cell carcinoma cell line:LU65	10487-107B1	10.90	1.38	2.75	5.85	2.07	0.57	0.34	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	7.28	4.34	3.64	1.96	3.36	0.98	1.26	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.49	2.24	0.50	3.24	2.49	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	4.12	8.23	1.90	1.16	2.96	0.74	0.53	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	3.93	10.39	1.69	1.83	3.09	0.28	1.12	0.70
glioblastoma cell line:T98G	10485-107A8	6.29	10.38	2.87	2.10	2.43	0.11	3.09	0.44
glioma cell line:GI-1	10413-106B8	10.84	7.61	1.76	2.93	0.88	0.29	2.34	0.00
globus pallidus - adult, donor10196	10175-103C4	10.20	5.10	4.37	2.19	5.83	1.46	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	26.61	4.64	3.91	6.59	3.91	1.71	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	16.43	1.37	2.74	5.48	4.11	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	12.26	4.80	3.20	3.73	2.13	3.20	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	14.68	0.00	24.47	4.89	29.37	4.89	9.79	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	5.23	5.23	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.64	3.52	2.56	2.88	2.56	0.64	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	6.89	0.92	2.75	4.13	2.75	0.92	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	5.94	2.29	1.83	3.20	1.37	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	3.22	1.29	1.93	4.51	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	4.31	1.44	1.44	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.17	0.00	2.06	1.37	0.69	1.37	0.69	0.00
hIPS, biol_rep3	14382-156B8	6.62	2.21	3.31	5.52	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2.30	0.29	0.00	2.59	0.57	0.00	0.00	0.29
heart - mitral valve, adult	10205-103F7	19.43	7.77	5.08	3.29	6.28	4.19	0.30	1.49
heart - pulmonic valve, adult	10206-103F8	15.17	4.97	5.75	5.75	5.49	1.57	0.00	1.57
heart - tricuspid valve, adult	10207-103F9	19.15	4.16	6.66	1.67	5.83	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	11.02	6.94	2.04	6.12	2.24	1.43	0.61	0.41
heart, adult, diseased, donor1	10051-101G6	10.65	0.85	0.85	4.26	2.98	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	18.17	1.38	4.60	2.76	2.76	0.92	0.00	0.69
heart, fetal, pool1	10046-101G1	35.12	6.37	6.37	14.27	7.91	2.57	0.62	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.79	1.85	1.23	0.62	1.54	0.62	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	36.86	8.32	2.38	10.70	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	8.95	1.33	0.88	2.65	0.55	0.22	0.00	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	6.07	1.34	1.70	4.37	0.97	0.24	0.24	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	6.27	1.11	2.02	3.33	1.82	0.61	0.20	0.30
hepatoma cell line:Li-7	10484-107A7	7.79	2.45	3.34	1.56	1.11	0.11	0.11	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	6.53	3.02	2.31	3.12	1.61	0.60	2.41	0.40
hippocampus - adult, donor10196	10169-103B7	11.36	2.84	4.73	6.62	4.73	0.95	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	21.84	5.92	6.12	8.16	5.31	1.43	1.43	0.20
hippocampus, adult, donor10258	10374-105G5	8.96	1.49	2.99	2.99	2.99	0.50	0.50	1.99
hippocampus, newborn, donor10223	10363-105F3	10.57	3.17	4.23	5.99	1.76	2.82	1.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	9.77	0.00	1.83	6.71	1.83	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.66	0.20	1.37	7.27	0.79	0.39	0.59	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.16	0.51	2.03	2.03	0.76	0.76	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.15	0.00	2.26	12.97	2.26	1.69	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	17.30	0.77	4.91	17.56	1.81	0.52	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	12.53	1.14	4.56	10.63	3.42	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.90	2.92	3.21	11.68	3.50	1.46	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.19	3.45	3.88	12.06	1.72	0.86	0.22	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	19.60	1.67	4.59	6.67	2.92	1.67	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.95	3.32	1.18	4.26	0.71	2.13	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	17.36	1.61	1.93	8.52	1.29	0.64	0.64	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	16.16	0.67	0.00	5.39	2.02	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	8.61	0.94	2.35	4.07	0.94	0.94	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.77	1.47	0.00	4.91	0.49	0.98	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	0.00	0.00	6.11	2.62	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	22.72	2.10	5.54	15.27	2.29	0.57	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.21	0.87	4.36	12.21	1.74	0.87	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	20.49	3.00	4.50	15.49	1.00	1.00	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.77	2.64	3.96	8.67	1.88	0.57	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	22.28	2.27	3.18	5.91	2.27	0.00	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.10	1.57	2.51	8.14	1.57	1.25	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.86	0.82	2.61	3.59	1.31	0.98	0.16	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.19	1.16	2.90	4.06	1.16	1.16	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.64	1.79	3.29	8.37	1.79	0.90	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	7.39	1.11	2.22	6.28	1.29	0.92	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.13	0.86	3.99	7.70	0.57	0.00	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	4.90	0.41	2.86	10.62	1.22	0.00	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	19.36	2.11	5.28	7.75	1.41	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	19.64	2.22	6.33	8.87	1.58	0.95	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.13	2.72	4.84	11.20	2.72	1.21	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.13	1.55	3.62	5.69	0.52	1.55	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.93	3.32	3.98	6.64	1.99	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	11.54	2.31	1.80	5.90	2.05	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.34	3.32	3.07	6.14	1.79	2.30	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	3.03	1.51	5.30	1.51	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	15.46	2.69	4.03	5.71	1.01	2.69	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	11.11	0.48	3.14	8.69	1.21	0.72	0.48	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.24	1.34	4.46	7.13	0.89	0.89	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.20	0.49	4.39	8.29	1.46	0.49	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	15.59	0.92	8.25	9.78	1.53	0.92	0.61	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	9.76	3.25	16.27	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	12.91	1.99	3.31	11.91	2.65	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.61	2.19	3.83	8.21	1.09	1.09	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	12.30	2.53	0.36	9.77	1.81	1.45	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.03	1.78	2.14	6.41	2.85	2.14	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	0.00	0.00	5.97	2.39	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.12	1.90	1.76	7.04	1.49	0.41	0.14	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.05	1.62	1.89	7.27	0.54	0.81	0.27	0.27
immature langerhans cells, donor1	11904-125F5	10.17	13.80	24.46	6.54	6.05	2.91	12.11	9.20
immature langerhans cells, donor2	11905-125F6	22.97	11.88	8.71	7.13	3.96	15.05	19.01	5.54
insula, adult, pool1	10039-101F3	20.35	5.11	5.49	8.61	5.58	1.80	1.32	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	6.83	0.33	0.33	2.60	1.30	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	13.62	4.51	3.30	2.30	2.10	1.70	0.20	0.10
kidney, fetal, pool1	10045-101F9	23.41	12.31	3.68	4.81	6.37	4.46	1.56	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	6.11	3.27	3.55	2.27	1.70	0.28	0.28	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1.52	0.69	1.38	1.66	0.97	0.14	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.95	17.07	2.39	2.02	4.59	1.28	1.65	1.10
left atrium, adult, donor1	10079-102A7	10.35	4.36	2.18	5.45	2.72	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	6.07	1.52	3.54	0.51	1.52	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	3.83	4.38	1.64	1.09	4.92	0.00	0.82	0.55
leiomyoma cell line:10964C	10569-108B2	3.95	3.59	0.36	0.36	1.44	1.44	1.80	0.00
leiomyoma cell line:15242A	10570-108B3	3.26	3.80	0.54	1.63	2.17	1.09	2.17	0.54
leiomyoma cell line:15425	10571-108B4	5.34	6.31	1.46	0.97	0.97	0.73	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	9.41	5.23	0.00	2.09	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	5.67	0.59	2.36	4.72	1.77	0.47	0.35	0.83
liposarcoma cell line:KMLS-1	10782-110G8	6.56	6.72	3.59	1.56	0.78	1.56	1.72	0.47
liposarcoma cell line:SW 872	10726-110A6	7.19	9.63	2.44	1.46	2.07	0.49	1.46	0.49
liver, adult, pool1	10018-101C9	18.47	8.59	5.51	2.76	2.76	3.08	0.32	0.49
liver, fetal, pool1	10086-102B5	9.41	3.76	3.76	2.82	1.88	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	21.58	10.35	3.50	3.50	5.98	5.25	0.58	0.87
locus coeruleus, adult, donor10252	10165-103B3	22.33	4.24	3.51	2.77	3.32	1.11	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	11.29	2.54	1.97	2.26	1.97	0.85	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	13.04	3.36	2.52	6.31	1.68	4.63	2.94	0.42
lung adenocarcinoma cell line:A549	10499-107C4	3.04	1.38	3.74	1.80	2.21	0.28	0.14	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	5.52	0.69	0.00	0.69	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	7.78	14.37	6.20	2.64	6.85	0.13	0.92	0.79
lung, adult, pool1	10019-101D1	15.83	3.66	6.38	2.72	5.91	1.06	0.59	1.06
lung, fetal, donor1	10068-101I5	17.41	15.41	10.85	3.14	12.56	6.28	0.57	2.85
lung, right lower lobe, adult, donor1	10075-102A3	11.00	3.21	4.58	4.58	2.29	3.21	0.92	1.83
lymph node, adult, donor1	10077-102A5	4.26	0.47	3.79	5.21	2.37	0.00	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	3.95	0.22	0.44	1.97	1.32	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.41	0.00	1.66	5.13	0.30	0.60	0.75	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	7.65	1.70	1.70	4.25	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	56.39	23.09	10.66	5.33	10.66	61.71	2.66	1.33
mature adipocyte, donor2	12232-129F9	51.26	19.09	8.30	4.36	8.51	19.72	2.28	2.08
mature adipocyte, donor3	12233-129G1	67.09	23.94	8.77	2.84	8.53	69.70	3.79	1.42
mature adipocyte, donor4	12234-129G2	36.59	14.48	8.95	3.95	9.21	25.01	2.11	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.48	1.67	3.10	8.10	2.86	1.19	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	1.13	4.51	6.77	2.26	1.13	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	27.22	2.57	3.31	5.70	2.94	1.10	1.29	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	12.39	1.27	2.22	2.54	5.08	0.64	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	8.53	8.10	3.84	8.96	5.12	0.43	2.56	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	20.08	3.71	4.22	10.80	5.57	1.35	1.18	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	27.16	2.76	3.61	5.52	2.76	0.85	1.49	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	3.85	3.85	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.82	5.74	5.03	8.97	3.95	2.51	3.95	1.08
medulla oblongata - adult, donor10196	10174-103C3	11.03	12.98	1.95	1.30	6.49	2.60	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	25.70	5.26	5.42	4.64	3.56	1.70	0.31	0.77
medulla oblongata, adult, pool1	10038-101F2	15.84	4.41	2.37	4.49	4.82	2.69	0.73	0.00
medulla oblongata, newborn, donor10223	10361-105F1	7.64	2.43	2.08	4.86	3.12	2.08	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	24.58	1.33	3.10	12.62	3.54	1.11	1.55	0.66
medulloblastoma cell line:ONS-76	10759-110E3	6.36	4.89	1.35	1.96	3.06	0.24	0.61	0.86
melanoma cell line:COLO 679	10514-107E1	10.92	4.60	1.87	5.17	2.59	0.43	2.16	0.72
melanoma cell line:G-361	10465-106H6	4.89	1.09	1.09	3.26	0.54	0.00	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	3.80	2.17	2.35	1.81	1.27	0.36	1.09	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	5.29	0.88	0.88	5.29	0.88	1.76	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	8.04	0.00	0.00	3.63	0.26	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	2.92	0.92	1.84	1.69	0.77	0.31	0.77	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.18	5.82	1.82	1.45	1.27	0.73	1.82	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.97	2.48	2.07	1.66	0.41	0.41	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2.11	3.37	1.26	0.28	0.56	0.42	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3.47	4.81	1.73	1.35	0.96	0.96	0.39	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	3.47	0.69	0.00	2.08	1.39	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.15	1.89	1.89	1.54	0.69	0.69	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.03	1.84	0.92	1.61	1.38	0.12	0.81	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4.51	1.99	2.52	0.93	0.93	0.00	0.80	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	2.57	2.30	1.08	0.81	0.54	0.14	0.54	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	4.98	4.98	2.56	2.28	1.14	0.00	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.95	2.31	3.29	1.65	1.32	0.00	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	3.87	2.08	2.08	1.80	0.55	0.69	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	3.84	2.79	1.05	0.35	1.05	0.35	0.70	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	3.47	4.08	2.04	1.43	1.22	0.20	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.95	2.52	2.16	1.80	0.72	0.36	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.24	3.72	1.66	0.72	1.55	0.10	0.52	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.33	9.58	1.37	0.46	1.82	2.05	1.82	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	0.84	6.71	1.68	0.84	0.84	0.84	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	3.14	2.99	1.20	0.90	0.30	0.45	1.05	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	3.33	1.23	1.05	1.58	0.53	0.00	0.79	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.15	0.74	3.68	4.05	1.10	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	4.01	2.00	2.58	2.29	0.86	1.43	0.86	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	6.32	6.32	2.95	3.37	0.84	0.84	1.26	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	12.33	2.28	1.37	2.28	0.46	3.20	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.91	14.58	4.09	1.28	2.81	1.53	3.58	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.85	14.40	5.24	0.52	2.88	1.31	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	6.47	11.40	2.16	1.54	3.08	1.54	4.01	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.41	13.65	2.12	1.65	3.06	1.65	5.88	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.77	7.78	2.03	2.03	2.37	1.69	4.06	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	5.50	11.00	1.18	0.39	2.75	0.79	3.93	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.63	12.97	3.71	0.46	0.46	0.93	3.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	5.48	12.40	2.88	2.02	4.04	1.73	3.46	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	4.24	9.37	1.56	0.67	2.45	1.34	4.02	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.33	12.98	2.64	0.48	2.16	0.72	3.85	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	12.47	0.73	2.20	3.67	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.36	11.08	1.68	1.34	1.34	1.34	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.73	11.87	2.87	1.64	2.46	1.23	3.28	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.44	8.59	1.72	0.86	1.72	0.86	2.58	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	2.73	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	3.25	6.17	0.97	1.62	0.97	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	4.36	0.00	0.00	1.45	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.20	4.80	0.53	2.13	2.67	0.00	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	2.45	3.27	1.64	2.45	0.00	0.00	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.50	4.28	2.33	0.78	0.78	0.78	2.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	6.30	0.00	2.10	2.10	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	2.98	2.98	1.99	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	3.56	4.74	0.59	0.00	0.59	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	3.66	0.00	1.22	1.22	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	4.43	3.17	0.00	0.00	0.00	1.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.86	4.14	1.38	1.03	1.03	0.34	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	1.63	0.81	1.22	0.81	0.81	0.41	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1.59	0.79	1.59	1.59	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	1.18	0.59	2.36	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	1.25	0.94	0.62	0.31	0.00	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	2.67	1.34	0.00	1.34	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	1.18	3.55	1.18	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	5.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2.07	1.38	2.07	1.38	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	2.97	3.46	2.97	0.99	1.98	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	5.61	0.00	2.24	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	5.09	2.54	0.64	0.64	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	2.01	1.61	1.21	0.81	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	4.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	3.80	1.27	2.53	0.00	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.64	5.46	5.46	1.21	1.82	2.43	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	0.00	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	6.59	2.47	1.65	0.82	2.47	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.17	1.19	1.98	0.60	0.20	0.20	0.60	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.19	2.27	0.65	1.62	0.97	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	1.02	2.04	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	4.64	5.42	0.00	5.42	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.03	19.37	4.49	1.42	4.96	0.71	1.18	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	7.65	8.34	2.32	1.39	1.16	0.70	2.78	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.01	6.06	2.06	2.88	2.26	0.62	0.62	0.31
mesothelioma cell line:Mero-25	10850-111F4	12.03	4.99	2.72	1.82	1.59	1.13	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	9.29	7.09	1.71	1.71	0.98	0.98	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	10.63	8.86	1.55	1.99	1.99	0.66	0.89	0.89
mesothelioma cell line:Mero-82	10853-111F7	10.25	3.42	1.31	1.05	1.31	0.53	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	6.13	5.28	1.19	1.36	1.36	0.68	0.51	0.34
mesothelioma cell line:Mero-84	10855-111F9	6.07	2.53	0.76	1.26	0.76	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	6.83	9.32	1.24	1.66	2.07	0.83	1.45	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	9.28	14.41	1.82	2.32	2.65	3.15	2.15	0.50
mesothelioma cell line:NCI-H226	10846-111E9	6.33	8.14	2.53	1.63	1.27	0.36	1.63	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	4.95	3.76	3.07	2.05	1.54	0.17	0.17	0.68
mesothelioma cell line:NCI-H28	10845-111E8	4.83	2.54	1.53	3.05	1.78	0.25	0.25	0.00
mesothelioma cell line:No36	10857-111G2	5.55	3.26	0.98	2.94	0.65	0.33	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	8.40	3.79	0.81	2.17	1.63	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	6.33	7.29	11.52	3.07	5.95	0.38	1.34	3.07
migratory langerhans cells, donor2	11902-125F3	7.82	6.96	9.89	4.03	5.74	0.61	0.37	2.44
migratory langerhans cells, donor3	11903-125F4	12.92	6.10	7.90	5.03	4.49	0.90	1.08	1.97
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	6.86	1.63	3.59	1.63	0.65	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.33	6.99	2.12	2.97	2.54	1.27	1.27	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.21	9.91	2.99	1.61	3.23	0.46	1.84	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1.52	0.57	1.90	1.71	0.95	0.38	0.57	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	5.73	0.55	1.66	3.51	1.85	0.18	0.55	0.18
myeloma cell line:PCM6	10474-106I6	3.16	0.20	1.38	2.57	1.58	0.20	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.12	25.87	2.03	1.52	8.12	0.00	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.71	3.53	2.55	3.53	1.37	0.78	1.37	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.68	3.23	1.34	1.45	2.12	1.67	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.18	2.79	1.10	1.76	1.32	0.74	0.29	0.29
nasal epithelial cells, donor2	12227-129F4	16.01	2.76	1.10	2.76	1.66	5.52	2.21	0.55
neuroblastoma cell line:CHP-134	10508-107D4	36.35	3.68	2.99	8.97	4.83	2.07	1.15	2.07
neuroblastoma cell line:NB-1	10539-107G8	8.23	1.68	2.25	2.25	2.43	0.56	0.19	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	9.07	0.00	1.48	3.59	0.21	0.84	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	8.01	1.30	1.12	6.89	1.30	0.75	1.30	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	10.44	0.24	1.42	5.69	0.00	0.71	0.95	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.68	0.32	3.33	5.86	1.90	0.63	1.11	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	6.64	0.00	0.20	3.02	0.00	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	24.16	0.00	1.27	0.64	0.00	0.64	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	6.39	3.73	1.86	2.40	1.33	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	29.75	29.75	0.00	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	6.76	4.90	5.24	6.60	8.79	0.85	1.35	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	3.20	0.00	0.00	1.60	0.80	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	16.03	5.13	2.24	2.56	2.24	2.24	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	6.04	8.93	1.31	1.84	1.58	0.53	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	15.65	3.09	4.03	6.00	2.91	3.00	1.50	0.47
occipital cortex - adult, donor10196	10172-103C1	6.18	4.12	4.12	2.06	0.00	2.06	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	28.71	6.17	8.86	8.32	5.10	1.88	1.61	0.81
occipital cortex, newborn, donor10223	10355-105E4	17.47	3.28	2.91	6.19	4.73	3.28	4.37	0.36
occipital lobe, adult, donor1	10076-102A4	30.44	2.10	3.67	12.33	5.25	4.72	2.36	0.79
occipital lobe, fetal, donor1	10073-102A1	33.04	3.00	5.58	12.87	5.58	2.15	0.86	0.43
occipital pole, adult, pool1	10036-101E9	15.22	2.44	3.55	5.68	5.05	1.10	1.26	0.63
olfactory region, adult	10195-103E6	12.42	3.44	4.20	7.45	4.39	1.91	0.38	0.76
optic nerve, donor1	10277-104E7	10.01	8.00	6.00	6.00	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	10.37	3.87	1.82	2.05	1.37	0.80	1.59	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.46	1.79	1.37	2.47	2.20	0.14	0.96	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.43	2.54	0.17	4.23	3.56	0.34	1.02	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.54	5.78	3.12	4.74	4.74	0.46	1.27	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	7.64	5.59	4.70	2.65	2.65	1.18	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	2.80	3.74	2.80	0.00	8.41	0.00	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	11.45	13.57	5.73	1.06	4.03	2.12	2.54	1.70
ovary, adult, pool1	10020-101D2	10.66	2.53	3.67	3.23	4.89	1.22	0.52	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.12	18.15	3.12	0.37	7.15	2.93	1.47	0.55
pancreas, adult, donor1	10049-101G4	6.58	0.94	1.88	0.94	2.82	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.98	8.11	2.80	5.31	3.35	0.56	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	6.30	2.73	0.34	3.24	1.19	0.51	1.53	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	10.76	7.78	6.46	2.98	3.81	0.50	1.82	1.82
paracentral gyrus, adult, pool1	10035-101E8	15.19	2.75	3.94	5.03	4.30	2.01	1.19	0.73
parietal cortex, adult, donor10258	10373-105G4	8.07	1.47	2.94	5.14	5.14	0.73	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	10.35	0.94	6.58	2.82	3.76	0.94	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	27.08	4.85	5.70	8.27	3.71	1.43	2.00	1.71
parietal lobe, adult, pool1	10034-101E7	17.54	1.85	3.35	6.87	4.23	2.56	1.15	0.88
parietal lobe, fetal, donor1	10072-101I9	43.64	1.94	3.88	13.58	1.94	1.94	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	12.71	8.22	6.36	7.48	5.23	1.50	1.87	0.37
parotid gland, adult	10199-103F1	6.78	1.23	1.23	1.85	1.23	0.62	0.00	0.00
penis, adult	10200-103F2	9.13	2.15	4.83	4.30	3.76	1.61	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.53	0.93	2.05	1.67	2.97	1.12	0.74	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.05	3.64	2.77	2.62	2.62	0.15	2.19	0.29
pineal gland - adult, donor10196	10179-103C8	12.90	2.58	3.23	5.81	11.61	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	24.28	0.59	1.78	14.21	4.15	1.18	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	11.91	5.64	1.25	8.15	5.02	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	10.12	4.05	4.05	3.04	3.04	2.02	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	26.06	0.52	5.73	8.86	5.73	2.08	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	8.51	0.00	0.85	3.40	2.55	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	11.83	8.28	2.26	5.38	5.16	0.97	0.65	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	4.90	0.93	3.71	3.18	1.19	0.26	2.12	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.45	6.23	1.25	2.65	2.49	0.31	0.62	0.62
pons, adult, pool1	10033-101E6	12.65	2.50	1.72	4.05	4.30	3.36	0.43	0.34
postcentral gyrus, adult, pool1	10032-101E5	15.34	2.01	3.49	7.24	3.84	1.74	1.05	1.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	2.09	10.46	0.00	20.91	0.00	2.09	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	11.74	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	4.52	8.01	2.62	3.50	1.89	0.00	2.04	0.44
prostate cancer cell line:PC-3	10439-106E7	7.99	9.62	2.18	2.54	3.45	1.63	1.45	0.36
prostate, adult, pool1	10022-101D4	8.71	2.00	4.17	3.81	3.08	0.54	0.09	0.45
putamen, adult, donor10196	10176-103C5	19.59	4.25	7.32	6.14	3.07	0.94	0.94	1.42
putamen, adult, donor10252	10152-102I8	3.92	0.00	3.92	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	3.28	1.09	2.19	5.46	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	6.28	2.66	1.93	5.07	1.21	0.48	0.72	0.97
putamen, newborn, donor10223	10365-105F5	7.50	5.25	0.75	7.50	1.50	0.75	3.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	15.13	11.93	4.07	1.45	6.40	0.58	1.16	0.87
rectum, fetal, donor1	10067-101I4	22.26	9.74	4.17	5.56	18.08	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.75	15.90	3.39	2.97	4.03	1.27	1.70	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.36	5.38	3.73	1.24	4.97	0.83	0.83	0.83
retina, adult, pool1	10030-101E3	13.72	3.08	4.27	8.45	5.07	0.80	0.40	0.40
retinoblastoma cell line:Y79	10475-106I7	2.08	0.26	1.56	2.86	1.04	0.00	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	8.61	8.48	2.34	0.86	2.95	0.86	1.11	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	26.15	6.47	6.19	10.69	3.94	2.25	0.56	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	2.27	8.34	1.52	2.27	1.52	0.76	3.03	0.00
salivary acinar cells, donor1	11771-123I7	3.08	2.43	0.49	1.46	0.97	0.97	0.16	0.16
salivary acinar cells, donor2	11772-123I8	6.47	1.51	1.38	3.86	3.03	0.55	0.41	0.14
salivary acinar cells, donor3	11773-123I9	7.28	4.63	1.32	4.63	9.93	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	9.72	0.57	1.14	1.72	1.72	1.72	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	6.07	6.07	3.71	3.29	3.04	0.34	1.52	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	5.88	6.00	3.88	3.17	2.70	0.12	1.41	0.24
seminal vesicle, adult	10201-103F3	11.64	4.76	2.12	7.41	6.88	6.88	1.59	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.63	13.85	3.89	2.92	4.13	1.70	3.16	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.03	1.51	1.26	1.26	0.25	0.00	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	9.03	2.01	7.02	6.02	3.01	2.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.73	1.61	0.94	1.48	0.94	0.13	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	6.30	1.22	1.88	1.99	1.55	0.00	0.55	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	2.97	1.68	2.45	4.13	2.06	0.13	0.00	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	5.67	2.84	2.13	2.84	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	18.23	2.40	3.24	5.88	3.60	1.08	0.36	0.84
skeletal muscle, fetal, donor1	10066-101I3	13.07	5.03	4.02	1.01	6.03	3.02	0.00	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	20.20	8.84	3.79	5.05	8.84	3.79	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	6.00	1.00	1.67	5.34	0.67	1.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	12.92	2.21	2.52	2.84	2.84	0.63	1.58	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	8.29	0.58	2.31	6.94	7.52	0.39	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	4.45	0.16	0.49	2.47	0.16	0.00	1.32	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	21.23	1.13	3.06	8.85	2.25	2.25	0.32	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	10.68	2.83	4.58	10.02	1.53	0.65	1.09	0.87
small intestine, adult, pool1	10024-101D6	15.41	6.57	6.45	5.26	6.69	0.96	1.19	1.43
small intestine, fetal, donor1	10064-101I1	12.53	3.69	3.69	4.67	3.69	0.74	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	7.69	3.59	2.56	4.10	2.05	0.00	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	17.57	5.43	4.65	4.91	4.91	0.78	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	7.77	2.14	0.54	1.61	4.56	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	16.06	11.01	2.29	2.75	8.49	1.15	0.69	0.46
spinal cord, adult, donor10252	10159-103A6	26.02	3.15	5.52	2.76	3.94	0.79	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	5.53	1.38	0.00	2.77	2.08	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	31.71	7.93	0.61	10.37	5.49	3.05	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	10.10	3.21	2.30	4.13	1.84	0.46	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.62	7.02	2.84	1.19	1.05	0.60	1.05	1.05
spleen, adult, pool1	10025-101D7	9.69	1.98	5.07	3.30	2.86	0.44	0.77	1.32
spleen, fetal, pool1	10044-101F8	16.45	5.88	7.39	5.16	5.24	3.81	0.95	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.14	1.04	2.07	3.62	0.93	0.83	0.93	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.75	2.47	3.80	3.23	3.80	0.00	0.38	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.51	10.83	2.10	5.24	2.45	1.05	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.42	22.67	8.60	2.35	8.60	0.00	4.30	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.88	2.59	2.59	2.93	2.81	0.79	1.13	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	0.85	1.27	2.54	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.46	12.69	6.35	2.54	5.92	1.27	2.96	0.42
stomach, fetal, donor1	10062-101H8	14.95	16.02	7.48	0.00	13.88	0.00	1.07	2.14
submaxillary gland, adult	10202-103F4	7.98	2.85	2.28	6.27	3.42	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.85	5.19	5.40	4.15	3.53	2.70	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	9.83	4.14	1.55	4.66	4.14	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	7.07	3.53	1.41	4.95	0.71	2.83	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.11	0.23	1.83	2.29	3.67	0.23	0.92	0.00
temporal lobe, adult, pool1	10031-101E4	19.50	2.03	3.90	6.70	4.83	2.20	1.10	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	34.90	4.27	2.85	10.68	9.26	4.99	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.45	3.08	4.40	16.70	5.27	2.20	1.76	1.32
tenocyte, donor1	11763-123H8	6.98	2.09	1.75	0.35	2.44	0.35	1.05	0.70
tenocyte, donor2	11765-123I1	4.96	3.82	0.38	0.76	0.76	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	4.08	1.48	1.85	2.22	0.74	0.37	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	4.76	0.68	0.34	3.57	0.68	0.51	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	11.25	2.00	5.09	5.09	1.39	0.62	0.46	0.46
teratocarcinoma cell line:PA-1	10807-111A6	11.00	1.70	3.10	3.87	1.08	0.31	0.31	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.84	1.14	1.52	4.70	1.52	1.02	0.25	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	11.72	0.38	3.03	4.92	1.51	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	5.45	2.51	1.64	2.94	4.47	0.22	0.65	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.17	0.00	0.33	5.21	0.65	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	18.47	1.72	5.26	9.34	6.33	3.11	0.54	0.43
testis, adult, pool2	10096-102C6	27.52	2.26	1.80	16.24	2.71	4.51	0.90	0.45
thalamus - adult, donor10196	10168-103B6	18.77	9.94	3.31	1.10	8.83	5.52	3.31	1.10
thalamus, adult, donor10252	10154-103A1	25.63	6.72	5.31	5.78	4.84	2.03	1.09	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	4.62	1.54	3.08	1.54	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.56	1.15	1.15	2.14	0.82	0.99	0.66	0.66
thalamus, newborn, donor10223	10366-105F6	5.75	3.45	0.58	6.90	1.73	0.00	1.15	0.00
throat, adult	10209-103G2	6.99	2.50	3.25	4.74	3.25	1.25	1.75	0.50
throat, fetal, donor1	10061-101H7	15.24	4.88	0.61	4.57	4.88	1.22	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	4.57	0.40	2.78	3.78	3.18	0.20	0.20	0.60
thymus, adult, pool1	10027-101D9	11.23	0.80	7.75	14.22	2.19	0.89	0.50	1.99
thymus, fetal, pool1	10043-101F7	26.81	1.77	8.42	15.69	3.12	3.01	0.94	2.60
thyroid carcinoma cell line:KHM-5M	10776-110G2	5.85	3.59	4.52	2.66	0.80	0.40	1.33	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	12.15	15.09	1.68	1.26	4.05	0.70	4.47	0.56
thyroid, adult, pool1	10028-101E1	8.86	1.68	3.36	1.96	3.36	0.75	0.19	0.28
thyroid, fetal, donor1	10060-101H6	17.93	5.54	2.37	4.22	3.95	5.27	2.37	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	12.32	6.16	6.16	15.40	6.16	0.00	0.00
tongue, adult	10203-103F5	10.23	3.72	2.56	3.72	1.16	1.86	1.40	0.70
tongue, fetal, donor1	10059-101H5	13.79	4.34	1.97	4.73	5.52	0.79	2.76	0.00
tonsil, adult, pool1	10047-101G2	10.42	4.51	5.61	5.11	4.11	1.60	1.90	1.40
trachea, adult, pool1	10029-101E2	6.30	1.96	3.03	3.35	2.37	0.74	0.08	0.65
trachea, fetal, donor1	10058-101H4	13.08	4.62	3.46	2.69	3.46	1.15	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.02	7.44	3.54	0.35	2.48	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	8.21	2.74	1.62	3.04	1.42	0.81	0.81	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.32	10.18	3.29	5.95	3.60	1.57	1.72	0.94
tridermal teratoma cell line:HGRT	10694-109G1	0.00	20.93	5.71	1.90	13.32	0.00	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	4.99	2.62	3.22	1.10	1.52	0.34	0.85	1.02
umbilical cord, fetal, donor1	10057-101H3	8.35	10.43	0.00	2.09	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	16.21	7.34	6.83	7.51	7.17	2.39	0.34	0.85
uterus, fetal, donor1	10055-101H1	13.82	16.89	3.58	2.05	5.63	2.56	2.05	0.00
vagina, adult	10204-103F6	10.34	3.23	15.51	2.58	3.23	0.65	0.00	1.94
vein, adult	10191-103E2	10.08	2.85	5.92	6.36	3.73	1.53	0.44	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.07	0.27	1.34	0.80	0.80	0.27	0.27	0.80